Disease on EC 2.3.1.21 - carnitine O-palmitoyltransferase
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
6-phosphofructokinase deficiency
Abnormal oxidative metabolism and O2 transport in muscle phosphofructokinase deficiency.
Acidosis
Brief report: renal tubular acidosis in carnitine palmitoyltransferase type 1 deficiency.
Acidosis
Rate-dependent distal renal tubular acidosis and carnitine palmitoyltransferase I deficiency.
Acidosis, Renal Tubular
Brief report: renal tubular acidosis in carnitine palmitoyltransferase type 1 deficiency.
Acidosis, Renal Tubular
Rate-dependent distal renal tubular acidosis and carnitine palmitoyltransferase I deficiency.
Acute Kidney Injury
Acute renal failure due to carnitine palmitoyltransferase II deficiency.
Acute Kidney Injury
An ignored cause of red urine in children: rhabdomyolysis due to carnitine palmitoyltransferase II (CPT-II) deficiency.
Acute Kidney Injury
Carnitine palmitoyl transferase II deficiency in an adolescent presenting with rhabdomyolysis and acute renal failure.
Acute Kidney Injury
Carnitine Palmitoyltransferase II Deficiency (CPT II) Followed By Rhabdomyolysis and Acute Kidney Injury.
Acute Kidney Injury
Carnitine palmitoyltransferase II deficiency due to a novel gene variant in a patient with rhabdomyolysis and ARF.
Acute Kidney Injury
Functional analysis of iPSC-derived myocytes from a patient with carnitine palmitoyltransferase II deficiency.
Acute Kidney Injury
[Acute renal insufficiency caused by rhabdomyolysis due to deficiency of carnitine palmitoyltransferase]
Acute Kidney Injury
[Mitochondrial activities of citrate synthase, carnitine palmitoyltransferase-1 and cytochrome C oxidase are increased during the apoptotic process in hepatocytes of a rat model of acute liver failure].
Acute Kidney Injury
[Rhabdomyolysis caused by carnitine palmitoyltransferase deficiency. Prevention of acute kidney failure]
acyl-coa dehydrogenase deficiency
Fatty Acid oxidation disorders in a chinese population in taiwan.
acyl-coa dehydrogenase deficiency
Follow-up of fatty acid ?-oxidation disorders in expanded newborn screening era.
acyl-coa dehydrogenase deficiency
In vivo stable isotope studies in three patients affected with mitochondrial fatty acid oxidation disorders: limited diagnostic use of 1-13C fatty acid breath test using bolus technique.
acyl-coa dehydrogenase deficiency
Therapeutic advances in the management of Pompe disease and other metabolic myopathies.
acyl-coa dehydrogenase deficiency
[Application of tandem mass spectrometry on the diagnosis of fatty acid oxidation disorders]
acyl-coa dehydrogenase deficiency
[Tandem mass spectrometry analysis and genetic diagnosis of neonates with fatty acid oxidation disorders in central and northern regions of Guangxi].
Adenocarcinoma
An indispensable role of CPT-1a to survive cancer cells during energy stress through rewiring cancer metabolism.
Alzheimer Disease
Carnitine palmitoyltransferase 1 (CPT1) alleviates oxidative stress and apoptosis of hippocampal neuron in response to beta-Amyloid peptide fragment A?25-35.
amp deaminase deficiency
Mutant carnitine palmitoyltransferase associated with myoadenylate deaminase deficiency in skeletal muscle.
Angina, Stable
Inhibition of long-chain fatty acid metabolism does not affect platelet aggregation responses.
Angina, Unstable
Inhibition of long-chain fatty acid metabolism does not affect platelet aggregation responses.
Aortic Valve Disease
Deciphering the gene expression profile of peroxisome proliferator-activated receptor signaling pathway in the left atria of patients with mitral regurgitation.
Asthma
Unmasking of carnitine palmitoyltransferase deficiency during an acute exacerbation of asthma complicated by rhabdomyolysis in a soldier.
Ataxia Telangiectasia
Resveratrol ameliorates high-fat diet-induced insulin resistance and fatty acid oxidation via ATM-AMPK axis in skeletal muscle.
Atherosclerosis
Carnitine palmitoyltransferase in patients with cardiac ischemia due to atherosclerotic coronary artery disease and in patients with idiopathic dilated cardiomyopathy.
Atherosclerosis
Lutein Prevents High Fat Diet-Induced Atherosclerosis in ApoE-Deficient Mice by Inhibiting NADPH Oxidase and Increasing PPAR Expression.
Atherosclerosis
[Effect of dachaihutang on expression of carnitine patmitoryl transferase-1 in vascular smooth muscle layer of atherosclerotic rabbits]
Azotemia
High-calorie diet partially ameliorates dysregulation of intrarenal lipid metabolism in remnant kidney.
Brain Diseases
A Case of Recurrent Acute Encephalopathy with Febrile Convulsive Status Epilepticus with Carnitine Palmitoyltransferase II Variation.
Brain Diseases
Abbreviated half-lives and impaired fuel utilization in carnitine palmitoyltransferase II variant fibroblasts.
Brain Diseases
Acute necrotizing encephalopathy and a carnitine palmitoyltransferase 2 variant in an adult.
Brain Diseases
Acute severe encephalopathy related to human herpesvirus-6 infection in a patient with carnitine palmitoyltransferase 2 deficiency carrying thermolabile variants.
Brain Diseases
Bezafibrate upregulates carnitine palmitoyltransferase II expression and promotes mitochondrial energy crisis dissipation in fibroblasts of patients with influenza-associated encephalopathy.
Brain Diseases
Carnitine palmitoyl transferase II polymorphism is associated with multiple syndromes of acute encephalopathy with various infectious diseases.
Brain Diseases
Characterization of compound missense mutation and deletion of carnitine palmitoyltransferase II in a patient with adenovirus-associated encephalopathy.
Brain Diseases
Energy metabolic disorder is a major risk factor in severe influenza virus infection: Proposals for new therapeutic options based on animal model experiments.
Brain Diseases
Fatal viral infection-associated encephalopathy in two Chinese boys: a genetically determined risk factor of thermolabile carnitine palmitoyltransferase II variants.
Brain Diseases
Newborn screening for carnitine palmitoyltransferase II deficiency using (C16+C18:1)/C2: Evaluation of additional indices for adequate sensitivity and lower false-positivity.
Brain Diseases
Normal muscle CPT1 and CPT2 activities in hepatic presentation patients with CPT1 deficiency in fibroblasts. Tissue specific isoforms of CPT1?
Brain Diseases
Novel metabolic and molecular findings in hepatic carnitine palmitoyltransferase I deficiency.
Brain Diseases
Pandemic influenza A-associated acute necrotizing encephalopathy without neurologic sequelae.
Brain Diseases
Severe Human Herpesvirus 6-associated Encephalopathy in Three Children: Analysis of Cytokine Profiles and the Carnitine Palmitoyltransferase 2 Gene.
Brain Diseases
Severe Hyperammonemic Encephalopathy Requiring Dialysis Aggravated by Prolonged Fasting and Intermittent High Fat Load in a Ramadan Fasting Month in a Patient with CPTII Homozygous Mutation.
Brain Diseases
Thermal instability of compound variants of carnitine palmitoyltransferase II and impaired mitochondrial fuel utilization in influenza-associated encephalopathy.
Brain Diseases
Thermolabile CPT II variants and low blood ATP levels are closely related to severity of acute encephalopathy in Japanese children.
Brain Diseases
Thermolabile phenotype of carnitine palmitoyltransferase II variations as a predisposing factor for influenza-associated encephalopathy.
Brain Diseases
Thermolabile polymorphism of carnitine palmitoyltransferase 2: A genetic risk factor of overall acute encephalopathy.
Brain Edema
Thermal instability of compound variants of carnitine palmitoyltransferase II and impaired mitochondrial fuel utilization in influenza-associated encephalopathy.
Brain Edema
Thermolabile CPT II variants and low blood ATP levels are closely related to severity of acute encephalopathy in Japanese children.
Brain Neoplasms
Poly-ion complex micelles effectively deliver CoA-conjugated CPT1A inhibitors to modulate lipid metabolism in brain cells.
Breast Neoplasms
Adipocyte lipolysis links obesity to breast cancer growth: adipocyte-derived fatty acids drive breast cancer cell proliferation and migration.
Breast Neoplasms
An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer.
Breast Neoplasms
C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity.
Breast Neoplasms
Carnitine palmitoyl transferase 1A is a novel diagnostic and predictive biomarker for breast cancer.
Breast Neoplasms
Carnitine palmitoyl transferase-1A (CPT1A): a new tumor specific target in human breast cancer.
Breast Neoplasms
CPT1A and fatty acid ?-oxidation are essential for tumor cell growth and survival in hormone receptor-positive breast cancer.
Breast Neoplasms
CPT1A regulates breast cancer-associated lymphangiogenesis via VEGF signaling.
Breast Neoplasms
Establishing a relationship between prolactin and altered fatty acid ?-oxidation via carnitine palmitoyl transferase 1 in breast cancer cells.
Breast Neoplasms
Fatty acid oxidation is associated with proliferation and prognosis in breast and other cancers.
Breast Neoplasms
Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity.
Breast Neoplasms
Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells.
Breast Neoplasms
In Situ Metabolic Characterisation of Breast Cancer and Its Potential Impact on Therapy.
Breast Neoplasms
Influence of DMBA-induced mammary cancer on the liver CPT I, mit HMG-CoA synthase and PPARalpha mRNA expression in rats fed a low or high corn oil diet.
Breast Neoplasms
Mechanism of apoptosis induced by the inhibition of fatty acid synthase in breast cancer cells.
Breast Neoplasms
Molecular characterization, genomic structure and expression analysis of a gene (CATL1/CPT1C) encoding a third member of the human carnitine acyltransferase family.
carbamoyl-phosphate synthase (ammonia) deficiency
Targeted metabolomic analysis of plasma samples for the diagnosis of inherited metabolic disorders.
carboxypeptidase t deficiency
A Novel Mutation in CPT1A Resulting in Hepatic CPT Deficiency.
carboxypeptidase t deficiency
Biochemical evidence for heterozygosity in muscular carnitine palmitoyltransferase deficiency.
carboxypeptidase t deficiency
Central nervous system disorders and possible brain type carnitine palmitoyltransferase II deficiency.
carboxypeptidase t deficiency
Human liver mitochondrial carnitine palmitoyltransferase I: characterization of its cDNA and chromosomal localization and partial analysis of the gene.
carboxypeptidase t deficiency
Inhibition of carnitine palmitoyltransferase (CPT) by chlorpromazine in muscle of patients with CPT deficiency.
carboxypeptidase t deficiency
Inhibition of carnitine palmitoyltransferase in normal human skeletal muscle and in muscle of patients with carnitine palmitoyltransferase deficiency by long- and short-chain acylcarnitine and acyl-coenzyme A.
carboxypeptidase t deficiency
Limited trypsin proteolysis renders carnitine palmitoyltransferase insensitive to inhibition by malonyl-CoA in patients with muscle carnitine palmitoyltransferase deficiency.
carboxypeptidase t deficiency
Regulatory properties of a mutant carnitine palmitoyltransferase in human skeletal muscle.
carboxypeptidase t deficiency
Selective carnitine palmitoyltransferase deficiency in fibroblasts from a patient with muscle CPT deficiency.
Carcinogenesis
Carnitine palmitoyltransferase 1C contributes to progressive cellular senescence.
Carcinogenesis
Carnitine palmitoyltransferase 1C regulates cancer cell senescence through mitochondria-associated metabolic reprograming.
Carcinogenesis
Depletion of the novel p53-target gene carnitine palmitoyltransferase 1C delays tumor growth in the neurofibromatosis type I tumor model.
Carcinogenesis
Development of a Genetic and Clinical Data-Based (GC) Risk Score for Predicting Survival of Hepatocellular Carcinoma Patients After Tumor Resection.
Carcinogenesis
Targeting CPT1A enhances metabolic therapy in human melanoma cells with the BRAF V600E mutation.
Carcinogenesis
Transcriptomic and Proteomic Analysis of Steatohepatitic Hepatocellular Carcinoma Reveals Novel Distinct Biologic Features.
Carcinoma
Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer.
Carcinoma
Carnitine palmitoyltransferase 1C regulates cancer cell senescence through mitochondria-associated metabolic reprograming.
Carcinoma
Carnitine palmitoyltransferase I in human carcinomas: a novel role in histone deacetylation?
Carcinoma
Identification of CPT1A as a Prognostic Biomarker and Potential Therapeutic Target for Kidney Renal Clear Cell Carcinoma and Establishment of a Risk Signature of CPT1A-Related Genes.
Carcinoma, Hepatocellular
?-Tocotrienol attenuates triglyceride through effect on lipogenic gene expressions in mouse hepatocellular carcinoma Hepa 1-6.
Carcinoma, Hepatocellular
Development of a Genetic and Clinical Data-Based (GC) Risk Score for Predicting Survival of Hepatocellular Carcinoma Patients After Tumor Resection.
Carcinoma, Hepatocellular
Loss of response of carnitine palmitoyltransferase I to okadaic acid in transformed hepatic cells.
Carcinoma, Hepatocellular
Metabolic profiling analysis upon acylcarnitines in tissues of hepatocellular carcinoma revealed the inhibited carnitine shuttle system caused by the downregulated carnitine palmitoyltransferase 2.
Carcinoma, Hepatocellular
Non-transplant therapies for patients with hepatocellular carcinoma and Child-Pugh-Turcotte class B cirrhosis.
Carcinoma, Hepatocellular
Positive regulation of hepatic carnitine palmitoyl transferase 1A (CPT1A) activities by soy isoflavones and L-carnitine.
Carcinoma, Hepatocellular
Purple Tea and Its Extract Suppress Diet-induced Fat Accumulation in Mice and Human Subjects by Inhibiting Fat Absorption and Enhancing Hepatic Carnitine Palmitoyltransferase Expression.
Carcinoma, Hepatocellular
Role of peroxisome proliferator-activated receptor alpha in the expression of hepatic fatty acid oxidation-related genes in chickens.
Carcinoma, Hepatocellular
Simultaneously targeting SOAT1 and CPT1A ameliorates hepatocellular carcinoma by disrupting lipid homeostasis.
Carcinoma, Hepatocellular
Transcriptomic and Proteomic Analysis of Steatohepatitic Hepatocellular Carcinoma Reveals Novel Distinct Biologic Features.
Carcinosarcoma
Carnitine palmitoyltransferase II activity is decreased in liver mitochondria of cachectic rats bearing the Walker 256 carcinosarcoma: effect of indomethacin treatment.
Cardiomegaly
Acute L-CPT1 Overexpression Recapitulates Reduced Palmitate Oxidation of Cardiac Hypertrophy.
Cardiomegaly
Apigenin ameliorates hypertension-induced cardiac hypertrophy and down-regulates cardiac hypoxia inducible factor-l? in rats.
Cardiomegaly
Carnitine palmitoyl transferase-I inhibition is not associated with cardiac hypertrophy in rats fed a high-fat diet.
Cardiomegaly
Carnitine Palmitoyltransferase-1b (CPT1b) Deficiency Aggravates Pressure-Overload-Induced Cardiac Hypertrophy due to Lipotoxicity.
Cardiomegaly
Comparison of the effects of carnitine palmitoyltransferase-1 and -2 inhibitors on rat heart hypertrophy.
Cardiomegaly
Down-regulation of acyl-CoA oxidase gene expression and increased NF-kappaB activity in etomoxir-induced cardiac hypertrophy.
Cardiomegaly
Etomoxir improves left ventricular performance of pressure-overloaded rat heart.
Cardiomegaly
Hypoglycemic effects of a novel fatty acid oxidation inhibitor in rats and monkeys.
Cardiomegaly
Improving characterization of hypertrophy-induced murine cardiac dysfunction using four-dimensional ultrasound-derived strain mapping.
Cardiomegaly
Modification of subcellular organelles in pressure-overloaded heart by etomoxir, a carnitine palmitoyltransferase I inhibitor.
Cardiomegaly
Octanoate is differentially metabolized in liver and muscle and fails to rescue cardiomyopathy in CPT2 deficiency.
Cardiomegaly
Overnourishment during lactation induces metabolic and haemodynamic heart impairment during adulthood.
Cardiomegaly
Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes.
Cardiomegaly
Transcribed Ultraconserved Regions, Uc.323, Ameliorates Cardiac Hypertrophy by Regulating the Transcription of CPT1b (Carnitine Palmitoyl transferase 1b).
Cardiomyopathies
Clinical and genetic characteristics of patients with fatty acid oxidation disorders identified by newborn screening.
Cardiomyopathies
Effect of L-carnitine supplementation on cardiac carnitine palmitoyltransferase activities and plasma carnitine concentrations in adriamycin-treated rats.
Cardiomyopathies
Lethal neonatal deficiency of carnitine palmitoyltransferase II associated with dysgenesis of the brain and kidneys.
Cardiomyopathies
Rhabdomyolysis and Cardiomyopathy in a 20-Year-Old Patient with CPT II Deficiency.
Cardiomyopathies
[An unusual case of cardiomyopathy showing carnitine palmitoyltransferase deficiency].
Cardiomyopathy, Dilated
Carnitine palmitoyltransferase in patients with cardiac ischemia due to atherosclerotic coronary artery disease and in patients with idiopathic dilated cardiomyopathy.
Cardiotoxicity
Inhibition of Gene Expression of Carnitine Palmitoyltransferase I and Heart Fatty Acid Binding Protein in Cyclophosphamide and Ifosfamide-Induced Acute Cardiotoxic Rat Models.
Cardiotoxicity
Inhibition of mitochondrial carnitine palmitoyltransferases by adriamycin and adriamycin analogues.
Cardiotoxicity
Propionyl-L-carnitine as potential protective agent against adriamycin-induced impairment of fatty acid beta-oxidation in isolated heart mitochondria.
Cardiovascular Diseases
Methylation at CPT1A locus is associated with lipoprotein subfraction profiles.
carnitine o-palmitoyltransferase deficiency
"Adult" form of muscular carnitine palmitoyltransferase II deficiency: manifestation in a 2-year-old child.
carnitine o-palmitoyltransferase deficiency
A case of carnitine palmitoyltransferase II deficiency in human skeletal muscle.
carnitine o-palmitoyltransferase deficiency
A case of partial carnitine palmitoyltransferase deficiency in a patient undergoing chronic hemodialysis.
carnitine o-palmitoyltransferase deficiency
A Japanese adult form of CPT II deficiency associated with a homozygous F383Y mutation.
carnitine o-palmitoyltransferase deficiency
A new nonsense mutation is associated with dysmorphism in lethal neonatal CPTII deficiency.
carnitine o-palmitoyltransferase deficiency
A newborn case with carnitine palmitoyltransferase II deficiency initially judged as unaffected by acylcarnitine analysis soon after birth.
carnitine o-palmitoyltransferase deficiency
A novel mutation identified in carnitine palmitoyltransferase II deficiency.
carnitine o-palmitoyltransferase deficiency
A Novel Mutation in CPT1A Resulting in Hepatic CPT Deficiency.
carnitine o-palmitoyltransferase deficiency
A novel nonsense mutation (515del4) in muscle carnitine palmitoyltransferase II deficiency.
carnitine o-palmitoyltransferase deficiency
A novel splice site mutation in neonatal carnitine palmitoyl transferase II deficiency.
carnitine o-palmitoyltransferase deficiency
A patient with atypical presentation of chronic hepatosteatosis and developmental delay harboring a novel variant in the CPT1A gene.
carnitine o-palmitoyltransferase deficiency
A retrospective ESI-MS/MS analysis of newborn blood spots from 18 symptomatic patients with organic acid and fatty acid oxidation disorders diagnosed either in infancy or in childhood.
carnitine o-palmitoyltransferase deficiency
A splice junction mutation in muscle carnitine palmitoyltransferase II deficiency.
carnitine o-palmitoyltransferase deficiency
A survey of Japanese patients with mitochondrial fatty acid beta-oxidation and related disorders as detected from 1985 to 2000.
carnitine o-palmitoyltransferase deficiency
A surviving 24-month-old patient with neonatal-onset carnitine palmitoyltransferase II deficiency.
carnitine o-palmitoyltransferase deficiency
Abbreviated half-lives and impaired fuel utilization in carnitine palmitoyltransferase II variant fibroblasts.
carnitine o-palmitoyltransferase deficiency
Abnormal CpG island methylation occurs during in vitro differentiation of human embryonic stem cells.
carnitine o-palmitoyltransferase deficiency
Abnormal oxidative metabolism and O2 transport in muscle phosphofructokinase deficiency.
carnitine o-palmitoyltransferase deficiency
Acute renal failure due to carnitine palmitoyltransferase deficiency.
carnitine o-palmitoyltransferase deficiency
Acute renal failure due to carnitine palmitoyltransferase II deficiency.
carnitine o-palmitoyltransferase deficiency
Acute Respiratory Infection Unveiling CPT II Deficiency.
carnitine o-palmitoyltransferase deficiency
Acute severe encephalopathy related to human herpesvirus-6 infection in a patient with carnitine palmitoyltransferase 2 deficiency carrying thermolabile variants.
carnitine o-palmitoyltransferase deficiency
Adult carnitine palmitoyltransferase II deficiency: detection of characteristic carnitine esters in serum by tandem mass spectrometry.
carnitine o-palmitoyltransferase deficiency
An unusual case of placenta increta in a Carnitine palmitoyltransferase deficiency carrier.
carnitine o-palmitoyltransferase deficiency
Anesthetic management of a parturient with carnitine palmitoyltransferase II deficiency.
carnitine o-palmitoyltransferase deficiency
Antenatal presentation of carnitine palmitoyltransferase II deficiency.
carnitine o-palmitoyltransferase deficiency
Approach to generalized weakness and peripheral neuromuscular disease.
carnitine o-palmitoyltransferase deficiency
Association of CPT II gene with risk of acute encephalitis in Chinese children.
carnitine o-palmitoyltransferase deficiency
Atypical features of the hepatic form of carnitine palmitoyltransferase deficiency in a Hutterite family.
carnitine o-palmitoyltransferase deficiency
Atypical Manifestation of CPT1A Deficiency: Hepatosplenomegaly And Nephromegaly.
carnitine o-palmitoyltransferase deficiency
Biochemical and molecular correlations in carnitine palmitoyltransferase II deficiency.
carnitine o-palmitoyltransferase deficiency
Biochemical and molecular studies of carnitine palmitoyltransferase II deficiency with hepatocardiomyopathic presentation.
carnitine o-palmitoyltransferase deficiency
Biochemical evidence for heterozygosity in muscular carnitine palmitoyltransferase deficiency.
carnitine o-palmitoyltransferase deficiency
Carnitine acyltransferases in normal human skeletal muscle and in muscle of patients with carnitine palmitoyltransferase deficiency.
carnitine o-palmitoyltransferase deficiency
Carnitine palmitoyl transferase 1A deficiency in an adult with recurrent severe steato hepatitis aggravated by high pathologic or physiologic demands: A roller-coaster for internists.
carnitine o-palmitoyltransferase deficiency
Carnitine palmitoyl transferase I deficiency presenting as a Reye-like syndrome without hypoglycaemia.
carnitine o-palmitoyltransferase deficiency
Carnitine palmitoyl transferase II deficiency in an adolescent presenting with rhabdomyolysis and acute renal failure.
carnitine o-palmitoyltransferase deficiency
Carnitine palmitoyltransferase 1A (CPT1A) P479L prevalence in live newborns in Yukon, Northwest Territories, and Nunavut.
carnitine o-palmitoyltransferase deficiency
Carnitine palmitoyltransferase 1A deficiency: abnormal muscle biopsy findings in a child presenting with Reye's syndrome.
carnitine o-palmitoyltransferase deficiency
Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer.
carnitine o-palmitoyltransferase deficiency
Carnitine Palmitoyltransferase 1b Deficiency Protects Mice from Diet-Induced Insulin Resistance.
carnitine o-palmitoyltransferase deficiency
Carnitine Palmitoyltransferase 1b Deficient Mice Develop Severe Insulin Resistance After Prolonged High Fat Diet Feeding.
carnitine o-palmitoyltransferase deficiency
Carnitine palmitoyltransferase 1C deficiency causes motor impairment and hypoactivity.
carnitine o-palmitoyltransferase deficiency
Carnitine palmitoyltransferase 2 deficiency: the time-course of blood and urinary acylcarnitine levels during initial L-carnitine supplementation.
carnitine o-palmitoyltransferase deficiency
Carnitine palmitoyltransferase deficiencies.
carnitine o-palmitoyltransferase deficiency
Carnitine palmitoyltransferase deficiency in a college athlete: a case report and literature review.
carnitine o-palmitoyltransferase deficiency
Carnitine palmitoyltransferase deficiency in pregnancy.
carnitine o-palmitoyltransferase deficiency
Carnitine palmitoyltransferase deficiency.
carnitine o-palmitoyltransferase deficiency
Carnitine palmitoyltransferase deficiency: a common cause of recurrent myoglobinuria.
carnitine o-palmitoyltransferase deficiency
Carnitine palmitoyltransferase deficiency: an underdiagnosed condition?
carnitine o-palmitoyltransferase deficiency
Carnitine palmitoyltransferase I deficiency in neonate identified by dried blood spot free carnitine and acylcarnitine profile.
carnitine o-palmitoyltransferase deficiency
Carnitine palmitoyltransferase IA polymorphism P479L is common in Greenland Inuit and is associated with elevated plasma apolipoprotein A-I.
carnitine o-palmitoyltransferase deficiency
Carnitine palmitoyltransferase II (CPT II) deficiency: genotype-phenotype analysis of 50 patients.
carnitine o-palmitoyltransferase deficiency
Carnitine Palmitoyltransferase II Deficiency (CPT II) Followed By Rhabdomyolysis and Acute Kidney Injury.
carnitine o-palmitoyltransferase deficiency
Carnitine palmitoyltransferase II deficiency and post-COVID vaccination rhabdomyolysis.
carnitine o-palmitoyltransferase deficiency
Carnitine palmitoyltransferase II deficiency due to a novel gene variant in a patient with rhabdomyolysis and ARF.
carnitine o-palmitoyltransferase deficiency
Carnitine palmitoyltransferase II deficiency in a prenatal case with polycystic kidney disease-like phenotype.
carnitine o-palmitoyltransferase deficiency
Carnitine palmitoyltransferase II deficiency with a focus on newborn screening.
carnitine o-palmitoyltransferase deficiency
Carnitine palmitoyltransferase II deficiency with normal carnitine palmitoyltransferase I in skeletal muscle and leucocytes.
carnitine o-palmitoyltransferase deficiency
Carnitine palmitoyltransferase II deficiency: a clinical, biochemical, and molecular review.
carnitine o-palmitoyltransferase deficiency
Carnitine palmitoyltransferase II deficiency: a new cause of recurrent pancreatitis.
carnitine o-palmitoyltransferase deficiency
Carnitine palmitoyltransferase II deficiency: diagnosis by molecular analysis of blood.
carnitine o-palmitoyltransferase deficiency
Carnitine palmitoyltransferase II deficiency: molecular and biochemical analysis of 32 patients.
carnitine o-palmitoyltransferase deficiency
Carnitine palmitoyltransferase II deficiency: structure of the gene and characterization of two novel disease-causing mutations.
carnitine o-palmitoyltransferase deficiency
Carnitine palmitoyltransferase II deficiency: successful anaplerotic diet therapy.
carnitine o-palmitoyltransferase deficiency
Carnitine Palmitoyltransferase-1b (CPT1b) Deficiency Aggravates Pressure-Overload-Induced Cardiac Hypertrophy due to Lipotoxicity.
carnitine o-palmitoyltransferase deficiency
Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects.
carnitine o-palmitoyltransferase deficiency
Carrier Frequency of a Common Mutation of Carnitine Palmitoyltransferase 1A Deficiency and Long-Term Follow-Up in Finland.
carnitine o-palmitoyltransferase deficiency
Cause of recurrent rhabdomyolysis, carnitine palmitoyltransferase II deficiency and novel pathogenic mutation.
carnitine o-palmitoyltransferase deficiency
Central nervous system disorders and possible brain type carnitine palmitoyltransferase II deficiency.
carnitine o-palmitoyltransferase deficiency
Ceramide levels regulated by carnitine palmitoyltransferase 1C control dendritic spine maturation and cognition.
carnitine o-palmitoyltransferase deficiency
Cerebral Lipid Accumulation Detected by MRS in a Child with Carnitine Palmitoyltransferase 2 Deficiency: A Case Report and Review of the Literature on Genetic Etiologies of Lipid Peaks on MRS.
carnitine o-palmitoyltransferase deficiency
Characterisation of carnitine palmitoyltransferases in patients with a carnitine palmitoyltransferase deficiency: implications for diagnosis and therapy.
carnitine o-palmitoyltransferase deficiency
Cholestatic Jaundice Associated with Carnitine Palmitoyltransferase IA Deficiency.
carnitine o-palmitoyltransferase deficiency
Clinical and biochemical heterogeneity in an Italian family with CPT II deficiency due to Ser 113 Leu mutation.
carnitine o-palmitoyltransferase deficiency
Clinical and genetic characteristics of patients with fatty acid oxidation disorders identified by newborn screening.
carnitine o-palmitoyltransferase deficiency
Clinical varieties of carnitine and carnitine palmitoyltransferase deficiency.
carnitine o-palmitoyltransferase deficiency
Clinically symptomatic heterozygous carnitine palmitoyltransferase II (CPT II) deficiency.
carnitine o-palmitoyltransferase deficiency
Complementation analysis of carnitine palmitoyltransferase I and II defects.
carnitine o-palmitoyltransferase deficiency
CPT2 gene mutations resulting in lethal neonatal or severe infantile carnitine palmitoyltransferase II deficiency.
carnitine o-palmitoyltransferase deficiency
Defects in activation and transport of fatty acids.
carnitine o-palmitoyltransferase deficiency
Detection of Early Onset Carnitine Palmitoyltransferase II Deficiency by Newborn Screening: Should CPT II Deficiency Be a Primary Disease Target?
carnitine o-palmitoyltransferase deficiency
Detection of neonatal carnitine palmitoyltransferase II deficiency by expanded newborn screening with tandem mass spectrometry.
carnitine o-palmitoyltransferase deficiency
Diagnostic assessment and long-term follow-up of 13 patients with Very Long-Chain Acyl-Coenzyme A dehydrogenase (VLCAD) deficiency.
carnitine o-palmitoyltransferase deficiency
Diagnostic pitfall in antenatal manifestations of CPT II deficiency.
carnitine o-palmitoyltransferase deficiency
Different ketogenic response to medium-chain triglycerides and to long-chain triglycerides in a case of muscular carnitine palmitoyltransferase deficiency.
carnitine o-palmitoyltransferase deficiency
Different sensitivities of CPT I and CPT II for inhibition by l-aminocarnitine in human skeletal muscle.
carnitine o-palmitoyltransferase deficiency
Disorders of fatty acid oxidation and autosomal recessive polycystic kidney disease-different clinical entities and comparable perinatal renal abnormalities.
carnitine o-palmitoyltransferase deficiency
Effect of diet on exercise tolerance in carnitine palmitoyltransferase II deficiency.
carnitine o-palmitoyltransferase deficiency
Elevated plasma carnitine in the hepatic form of carnitine palmitoyltransferase-1 deficiency.
carnitine o-palmitoyltransferase deficiency
Evaluation of Metabolic Defects in Fatty Acid Oxidation Using Peripheral Blood Mononuclear Cells Loaded with Deuterium-Labeled Fatty Acids.
carnitine o-palmitoyltransferase deficiency
Exercise tolerance in carnitine palmitoyltransferase II deficiency with IV and oral glucose.
carnitine o-palmitoyltransferase deficiency
Exercise, Nutrition, and Supplements in the Muscle Carnitine Palmitoyl-Transferase II Deficiency: New Theoretical Bases for Potential Applications.
carnitine o-palmitoyltransferase deficiency
Exertional rhabdomyolysis leading to acute kidney injury: when genetic defects are diagnosed in adult life.
carnitine o-palmitoyltransferase deficiency
Expression analysis of two mutations in carnitine palmitoyltransferase IA deficiency.
carnitine o-palmitoyltransferase deficiency
Fatal carnitine palmitoyltransferase II deficiency in a newborn: new phenotypic features.
carnitine o-palmitoyltransferase deficiency
Fatty Acid oxidation disorders in a chinese population in taiwan.
carnitine o-palmitoyltransferase deficiency
Features of carnitine palmitoyltransferase type I deficiency.
carnitine o-palmitoyltransferase deficiency
First Japanese Case of Carnitine Palmitoyltransferase II Deficiency with the Homozygous Point Mutation S113L.
carnitine o-palmitoyltransferase deficiency
Fuel utilization in subjects with carnitine palmitoyltransferase 2 gene mutations.
carnitine o-palmitoyltransferase deficiency
Functional analysis of iPSC-derived myocytes from a patient with carnitine palmitoyltransferase II deficiency.
carnitine o-palmitoyltransferase deficiency
Functional and structural basis of carnitine palmitoyltransferase 1A deficiency.
carnitine o-palmitoyltransferase deficiency
Genetic risk factors associated with lipid-lowering drug-induced myopathies.
carnitine o-palmitoyltransferase deficiency
Genetics of carnitine palmitoyltransferase II deficiencies.
carnitine o-palmitoyltransferase deficiency
Genotype-phenotype correlations in a large series of patients with muscle type CPT II deficiency.
carnitine o-palmitoyltransferase deficiency
Hepatic carnitine palmitoyltransferase I deficiency presenting as maternal illness in pregnancy.
carnitine o-palmitoyltransferase deficiency
Hepatic carnitine palmitoyltransferase I deficiency: acylcarnitine profiles in blood spots are highly specific.
carnitine o-palmitoyltransferase deficiency
High frequency of ETFDH c.250G>A mutation in Taiwanese patients with late-onset lipid storage myopathy.
carnitine o-palmitoyltransferase deficiency
Human liver mitochondrial carnitine palmitoyltransferase I: characterization of its cDNA and chromosomal localization and partial analysis of the gene.
carnitine o-palmitoyltransferase deficiency
Hypercholesterolemia treatment in a patient with family hypercholesterolemia and myopathy due to carnitine palmitoyltransferase II deficiency with PCSK9 inhibitors.
carnitine o-palmitoyltransferase deficiency
Hyperlipidaemia due to carnitine palmitoyltransferase I deficiency.
carnitine o-palmitoyltransferase deficiency
Identification by mutagenesis of a conserved glutamate (Glu487) residue important for catalytic activity in rat liver carnitine palmitoyltransferase II.
carnitine o-palmitoyltransferase deficiency
Identification of 16 new disease-causing mutations in the CPT2 gene resulting in carnitine palmitoyltransferase II deficiency.
carnitine o-palmitoyltransferase deficiency
Identification of a common mutation in the carnitine palmitoyltransferase II gene in familial recurrent myoglobinuria patients.
carnitine o-palmitoyltransferase deficiency
Identification of four novel mutations in patients with carnitine palmitoyltransferase II (CPT II) deficiency.
carnitine o-palmitoyltransferase deficiency
Identification of novel mutations in Spanish patients with muscle carnitine palmitoyltransferase II deficiency.
carnitine o-palmitoyltransferase deficiency
Immunoquantitative analysis of human carnitine palmitoyltransferase I and II defects.
carnitine o-palmitoyltransferase deficiency
In vivo stable isotope studies in three patients affected with mitochondrial fatty acid oxidation disorders: limited diagnostic use of 1-13C fatty acid breath test using bolus technique.
carnitine o-palmitoyltransferase deficiency
Increased serum lactate dehydrogenase isoenzyme 1 and "flipped" LD-1/LD-2 ratio in myopathy associated with partial carnitine palmitoyltransferase deficiency.
carnitine o-palmitoyltransferase deficiency
Infantile form of carnitine palmitoyltransferase II deficiency in a girl with rapid fatal onset.
carnitine o-palmitoyltransferase deficiency
Infantile form of carnitine palmitoyltransferase II deficiency with hepatomuscular symptoms and sudden death. Physiopathological approach to carnitine palmitoyltransferase II deficiencies.
carnitine o-palmitoyltransferase deficiency
Inheritance of the S113L mutation within an inbred family with carnitine palmitoyltransferase enzyme deficiency.
carnitine o-palmitoyltransferase deficiency
Inhibition of carnitine palmitoyltransferase in normal human skeletal muscle and in muscle of patients with carnitine palmitoyltransferase deficiency by long- and short-chain acylcarnitine and acyl-coenzyme A.
carnitine o-palmitoyltransferase deficiency
Laryngeal spasm mimicking asthma and vitamin d deficiency.
carnitine o-palmitoyltransferase deficiency
Lethal neonatal and severe late infantile forms of carnitine palmitoyltransferase II deficiency associated with compound heterozygosity for different protein truncation mutations.
carnitine o-palmitoyltransferase deficiency
Lethal neonatal carnitine palmitoyltransferase II deficiency: an unusual presentation of a rare disorder.
carnitine o-palmitoyltransferase deficiency
Lethal neonatal presentation of carnitine palmitoyltransferase I deficiency.
carnitine o-palmitoyltransferase deficiency
Limited trypsin proteolysis renders carnitine palmitoyltransferase insensitive to inhibition by malonyl-CoA in patients with muscle carnitine palmitoyltransferase deficiency.
carnitine o-palmitoyltransferase deficiency
Lipids detected by brain MRS during coma caused by carnitine palmitoyltransferase 1 deficiency.
carnitine o-palmitoyltransferase deficiency
Long-chain acyl-CoA profiles in cultured fibroblasts from patients with defects in fatty acid oxidation.
carnitine o-palmitoyltransferase deficiency
Long-term follow-up of bezafibrate treatment in patients with the myopathic form of carnitine palmitoyltransferase 2 deficiency.
carnitine o-palmitoyltransferase deficiency
Macro creatine kinase in a case of carnitine palmitoyltransferase deficiency.
carnitine o-palmitoyltransferase deficiency
Malignant hyperthermia-like syndrome and carnitine palmitoyltransferase II deficiency with heterozygous R503C mutation.
carnitine o-palmitoyltransferase deficiency
Malonyl-CoA abnormal inhibition of residual enzyme activity in carnitine palmitoyltransferase deficiency.
carnitine o-palmitoyltransferase deficiency
Metabolic autopsy with next generation sequencing in sudden unexpected death in infancy: Postmortem diagnosis of fatty acid oxidation disorders.
carnitine o-palmitoyltransferase deficiency
Metabolic characterization of a woman homozygous for the Ser113Leu missense mutation in carnitine palmitoyl transferase II.
carnitine o-palmitoyltransferase deficiency
Molecular analysis in Spanish patients with muscle carnitine palmitoyltransferase deficiency.
carnitine o-palmitoyltransferase deficiency
Molecular analysis of carnitine palmitoyltransferase II deficiency with hepatocardiomuscular expression.
carnitine o-palmitoyltransferase deficiency
Molecular and enzymatic characterization of a unique carnitine palmitoyltransferase 1A mutation in the Hutterite community.
carnitine o-palmitoyltransferase deficiency
Molecular assay for detection of the common carnitine palmitoyltransferase 1A 1436(C>T) mutation.
carnitine o-palmitoyltransferase deficiency
Molecular basis of hepatic carnitine palmitoyltransferase I deficiency.
carnitine o-palmitoyltransferase deficiency
Molecular characterization of inherited carnitine palmitoyltransferase II deficiency.
carnitine o-palmitoyltransferase deficiency
Muscle Carnitine Palmitoyltransferase II (CPT II) Deficiency: A Conceptual Approach.
carnitine o-palmitoyltransferase deficiency
Muscle Carnitine Palmitoyltransferase II Deficiency: A Review of Enzymatic Controversy and Clinical Features.
carnitine o-palmitoyltransferase deficiency
Muscle carnitine palmitoyltransferase II deficiency: clinical and molecular genetic features and diagnostic aspects.
carnitine o-palmitoyltransferase deficiency
Muscular carnitine palmitoyltransferase II deficiency in infancy.
carnitine o-palmitoyltransferase deficiency
Mutations of carnitine palmitoyltransferase II (CPT II) in Japanese patients with CPT II deficiency.
carnitine o-palmitoyltransferase deficiency
Myocardial carnitine and carnitine palmitoyltransferase deficiencies in patients with severe heart failure.
carnitine o-palmitoyltransferase deficiency
Need for strict clinical management of patients with carnitine palmitoyltransferase II deficiency: Experience with two cases detected by expanded newborn screening.
carnitine o-palmitoyltransferase deficiency
Neonatal carnitine palmitoyltransferase deficiency: a case with a muscular presentation.
carnitine o-palmitoyltransferase deficiency
Neonatal carnitine palmitoyltransferase II deficiency associated with Dandy-Walker syndrome and sudden death.
carnitine o-palmitoyltransferase deficiency
Neonatal Carnitine Palmitoyltransferase II Deficiency: A Lethal Entity.
carnitine o-palmitoyltransferase deficiency
Neonatal carnitine palmitoyltransferase II deficiency: failure of treatment despite prolonged survival.
carnitine o-palmitoyltransferase deficiency
New developments in the diagnosis and investigation of mitochondrial fatty acid oxidation disorders.
carnitine o-palmitoyltransferase deficiency
Newborn screening for carnitine palmitoyltransferase II deficiency using (C16+C18:1)/C2: Evaluation of additional indices for adequate sensitivity and lower false-positivity.
carnitine o-palmitoyltransferase deficiency
No carnitine palmitoyltransferase deficiency in skeletal muscle in 18 malignant hyperthermia susceptible individuals.
carnitine o-palmitoyltransferase deficiency
Noninvasive evaluation of adult onset myopathy from carnitine palmitoyl transferase II deficiency using proton magnetic resonance spectroscopy.
carnitine o-palmitoyltransferase deficiency
Normal FGF-21-Serum Levels in Patients with Carnitine Palmitoyltransferase II (CPT II) Deficiency.
carnitine o-palmitoyltransferase deficiency
Normal Levels of Plasma Free Carnitine and Acylcarnitines in Follow-Up Samples from a Presymptomatic Case of Carnitine Palmitoyl Transferase 1 (CPT1) Deficiency Detected Through Newborn Screening in Denmark.
carnitine o-palmitoyltransferase deficiency
Normal protein content but abnormally inhibited enzyme activity in muscle carnitine palmitoyltransferase II deficiency.
carnitine o-palmitoyltransferase deficiency
Novel metabolic and molecular findings in hepatic carnitine palmitoyltransferase I deficiency.
carnitine o-palmitoyltransferase deficiency
Novel mutation in carnitine palmitoyltransferase 1A detected through newborn screening for a presymptomatic case in China: a case report.
carnitine o-palmitoyltransferase deficiency
Novel mutation in the CPT II gene in a child with periodic febrile myalgia and myoglobinuria.
carnitine o-palmitoyltransferase deficiency
Novel mutations associated with carnitine palmitoyltransferase II deficiency.
carnitine o-palmitoyltransferase deficiency
Novel mutations in CPT 1A define molecular heterogeneity of hepatic carnitine palmitoyltransferase I deficiency.
carnitine o-palmitoyltransferase deficiency
Novel mutations in myopathic form of carnitine palmitoyltransferase II deficiency in a Chinese patient.
carnitine o-palmitoyltransferase deficiency
Novel Mutations in the CPT1A Gene Identified in the Patient Presenting Jaundice as the First Manifestation of Carnitine Palmitoyltransferase 1A Deficiency.
carnitine o-palmitoyltransferase deficiency
Novel mutations in the gene encoding very long-chain acyl-CoA dehydrogenase identified in patients with partial carnitine palmitoyltransferase II deficiency.
carnitine o-palmitoyltransferase deficiency
Novel Regulation of the Synthesis of ?-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Subunit GluA1 by Carnitine Palmitoyltransferase 1C (CPT1C) in the Hippocampus.
carnitine o-palmitoyltransferase deficiency
Nutrition and Exercise in a Case of Carnitine Palmitoyl-Transferase II Deficiency.
carnitine o-palmitoyltransferase deficiency
Partial muscle carnitine palmitoyltransferase-A deficiency. Rhabdomyolysis associated with transiently decreased muscle carnitine content after ibuprofen therapy.
carnitine o-palmitoyltransferase deficiency
Pathophysiological approach to carnitine palmitoyltransferase II deficiencies.
carnitine o-palmitoyltransferase deficiency
Phenotype of carnitine palmitoyltransferase II (CPT II) deficiency: A questionnaire-based survey.
carnitine o-palmitoyltransferase deficiency
Phenotypic variability among first-degree relatives with carnitine palmitoyltransferase II deficiency.
carnitine o-palmitoyltransferase deficiency
Post-mortem MRI reveals CPT2 deficiency after sudden infant death.
carnitine o-palmitoyltransferase deficiency
Postinfectious Rhabdomyolysis in a 5-Year-Old Boy: When to Look a Little Deeper.
carnitine o-palmitoyltransferase deficiency
Postoperative coma in a child with carnitine palmitoyltransferase I deficiency.
carnitine o-palmitoyltransferase deficiency
Prenatal diagnosis of carnitine palmitoyltransferase 2 deficiency in chorionic villi: a novel approach.
carnitine o-palmitoyltransferase deficiency
Prevalence and Distribution of the c.1436C?T Sequence Variant of Carnitine Palmitoyltransferase 1A among Alaska Native Infants.
carnitine o-palmitoyltransferase deficiency
Profound carnitine palmitoyltransferase II deficiency.
carnitine o-palmitoyltransferase deficiency
Quantitative acylcarnitine profiling in fibroblasts using [U-13C] palmitic acid: an improved tool for the diagnosis of fatty acid oxidation defects.
carnitine o-palmitoyltransferase deficiency
Rapid, cost-effective gene mutation screening for carnitine palmitoyltransferase II deficiency using whole blood on filter paper.
carnitine o-palmitoyltransferase deficiency
Rate-dependent distal renal tubular acidosis and carnitine palmitoyltransferase I deficiency.
carnitine o-palmitoyltransferase deficiency
Rationale for a conditional knockout mouse model to study carnitine palmitoyltransferase I deficiencies.
carnitine o-palmitoyltransferase deficiency
Recurrent metabolic decompensation in profound carnitine palmitoyltransferase II deficiency.
carnitine o-palmitoyltransferase deficiency
Recurrent Myalgia since Early Infancy-Misleading Clinical Course in a Child with Carnitine Palmitoyltransferase-II Deficiency.
carnitine o-palmitoyltransferase deficiency
Recurrent myoglobinuria due to carnitine palmitoyltransferase II deficiency: clinical, biochemical, and genetic features of adult-onset cases.
carnitine o-palmitoyltransferase deficiency
Recurrent myoglobinuria due to carnitine palmitoyltransferase II deficiency: expression of the molecular phenotype in cultured muscle cells.
carnitine o-palmitoyltransferase deficiency
Recurrent rhabdomyolysis caused by carnitine palmitoyltransferase II deficiency, common but under-recognised: Lessons to be learnt.
carnitine o-palmitoyltransferase deficiency
Recurrent rhabdomyolysis in a collegiate athlete: a case report.
carnitine o-palmitoyltransferase deficiency
Repeat MRI in acute rhabdomyolysis: correlation with clinicopathological findings.
carnitine o-palmitoyltransferase deficiency
Repeated and progressive rhabdomyolysis due to a novel carnitine palmitoyltransferase II gene variant in an adult male: A case report.
carnitine o-palmitoyltransferase deficiency
Retrospective review of Japanese sudden unexpected death in infancy: The importance of metabolic autopsy and expanded newborn screening.
carnitine o-palmitoyltransferase deficiency
Reversible asphyxial status in a newborn due to neonatal form of carnitine palmitoyltransferase II deficiency.
carnitine o-palmitoyltransferase deficiency
Rhabdomyolysis and Cardiomyopathy in a 20-Year-Old Patient with CPT II Deficiency.
carnitine o-palmitoyltransferase deficiency
Rhabdomyolysis and respiratory failure: rare presentation of carnitine palmityl-transferase II deficiency.
carnitine o-palmitoyltransferase deficiency
Rhabdomyolysis caused by carnitine palmitoyltransferase 2 deficiency: A case report and systematic review of the literature.
carnitine o-palmitoyltransferase deficiency
Rhabdomyolysis with different etiologies in childhood.
carnitine o-palmitoyltransferase deficiency
Screening for carnitine palmitoyltransferase II deficiency by tandem mass spectrometry.
carnitine o-palmitoyltransferase deficiency
Secondary carnitine palmitoyltransferase deficiency in chronic renal failure and secondary hyperparathyroidism.
carnitine o-palmitoyltransferase deficiency
Selective carnitine palmitoyltransferase deficiency in fibroblasts from a patient with muscle CPT deficiency.
carnitine o-palmitoyltransferase deficiency
Selective screening for fatty acid oxidation disorders by tandem mass spectrometry: difficulties in practical discrimination.
carnitine o-palmitoyltransferase deficiency
Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: a four-year report.
carnitine o-palmitoyltransferase deficiency
Serious pregnancy complications in a patient with previously undiagnosed carnitine palmitoyltransferase 1 deficiency.
carnitine o-palmitoyltransferase deficiency
Severe Hyperammonemic Encephalopathy Requiring Dialysis Aggravated by Prolonged Fasting and Intermittent High Fat Load in a Ramadan Fasting Month in a Patient with CPTII Homozygous Mutation.
carnitine o-palmitoyltransferase deficiency
SEVERE INFANTILE CARNITINE PALMITOYLTRANSFERASE II (CPT II) DEFICIENCY IN 19-WEEK FETAL SIBS.
carnitine o-palmitoyltransferase deficiency
Severe periodic febrile myalgia in infancy due to carnitine palmitoyltransferase deficiency.
carnitine o-palmitoyltransferase deficiency
Severe rhabdomyolysis in homozygote carnitine palmitoyltransferase II deficiency.
carnitine o-palmitoyltransferase deficiency
Severe rhabdomyolysis with hypoglycemia in an adult patient with carnitine palmitoyltransferase II deficiency.
carnitine o-palmitoyltransferase deficiency
Skeletal muscle-specific CPT1 deficiency elevates lipotoxic intermediates but preserves insulin sensitivity.
carnitine o-palmitoyltransferase deficiency
Stabilization of the thermolabile variant S113L of carnitine palmitoyltransferase II.
carnitine o-palmitoyltransferase deficiency
Statin use in carnitine palmitoyltransferase II deficiency.
carnitine o-palmitoyltransferase deficiency
Study of Carnitine/Acylcarnitine and Aminoacid Profile in children and adults with Acute Liver Failure.
carnitine o-palmitoyltransferase deficiency
Subclinical effects of long-chain fatty acid ?-oxidation deficiency on the adult heart: A case-control magnetic resonance study.
carnitine o-palmitoyltransferase deficiency
Successful long-term treatment of hepatic carnitine palmitoyltransferase I deficiency and a novel mutation.
carnitine o-palmitoyltransferase deficiency
Successful orthotopic heart transplantation in CPTII deficiency.
carnitine o-palmitoyltransferase deficiency
Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program.
carnitine o-palmitoyltransferase deficiency
Task force guidelines handbook: EFNS guidelines on diagnosis and management of fatty acid mitochondrial disorders.
carnitine o-palmitoyltransferase deficiency
The crystal structure of carnitine palmitoyltransferase 2 and implications for diabetes treatment.
carnitine o-palmitoyltransferase deficiency
The diagnosis of carnitine palmitoyltransferase II deficiency is now possible in small skeletal muscle biopsies.
carnitine o-palmitoyltransferase deficiency
The role of mitochondria in statin-induced myopathy.
carnitine o-palmitoyltransferase deficiency
Therapeutic advances in the management of Pompe disease and other metabolic myopathies.
carnitine o-palmitoyltransferase deficiency
Trifunctional enzyme deficiency: adult presentation of a usually fatal beta-oxidation defect.
carnitine o-palmitoyltransferase deficiency
Two CPT2 mutations in three Japanese patients with carnitine palmitoyltransferase II deficiency: functional analysis and association with polymorphic haplotypes and two clinical phenotypes.
carnitine o-palmitoyltransferase deficiency
Two novel gene mutations (Glu174-->Lys, Phe383-->Tyr) causing the "hepatic" form of carnitine palmitoyltransferase II deficiency.
carnitine o-palmitoyltransferase deficiency
Unmasking of carnitine palmitoyltransferase deficiency during an acute exacerbation of asthma complicated by rhabdomyolysis in a soldier.
carnitine o-palmitoyltransferase deficiency
Unrecognized High Occurrence of Genetically Confirmed Hereditary Carnitine Palmitoyltransferase II Deficiency in an Austrian Family Points to the Ongoing Underdiagnosis of the Disease.
carnitine o-palmitoyltransferase deficiency
Utility of Genetic Testing for Confirmation of Abnormal Newborn Screening in Disorders of Long-Chain Fatty Acids: A Missed Case of Carnitine Palmitoyltransferase 1A (CPT1A) Deficiency.
carnitine o-palmitoyltransferase deficiency
[A case report of carnitine palmitoyltransferase II deficiency]
carnitine o-palmitoyltransferase deficiency
[A female case of carnitine palmitoyltransferase deficiency]
carnitine o-palmitoyltransferase deficiency
[Acute respiratory insufficiency and carnitine palmitoyltransferase deficiency]
carnitine o-palmitoyltransferase deficiency
[Alterations of mitochondria in metabolic diseases. Carnitine deficiency, carnitine palmitoyltransferase deficiency and beta oxidation.]
carnitine o-palmitoyltransferase deficiency
[An unusual case of cardiomyopathy showing carnitine palmitoyltransferase deficiency].
carnitine o-palmitoyltransferase deficiency
[Analysis of a child with carnitine palmitoyl transferase 1A deficiency due to variant of CPT1A gene].
carnitine o-palmitoyltransferase deficiency
[Anesthetic management of a patient with carnitine palmitoyltransferase deficiency with a history of rhabdomyolysis].
carnitine o-palmitoyltransferase deficiency
[Application of tandem mass spectrometry on the diagnosis of fatty acid oxidation disorders]
carnitine o-palmitoyltransferase deficiency
[Carnitine palmitoyltransferase deficiency (I, II)]
carnitine o-palmitoyltransferase deficiency
[Carnitine palmitoyltransferase deficiency as the cause of effort rhabdomyolysis]
carnitine o-palmitoyltransferase deficiency
[Carnitine palmitoyltransferase deficiency in a patient with severe psychomotor retardation]
carnitine o-palmitoyltransferase deficiency
[Carnitine palmitoyltransferase deficiency: fatty acid utilization defect causing myopathy]
carnitine o-palmitoyltransferase deficiency
[Clinical aspects of disorders of lipid metabolism in humans. II. Carnitine palmitoyltransferase deficiency]
carnitine o-palmitoyltransferase deficiency
[Clinical features and gene mutations of 6 patients with carnitine palmitoyltransferase 1A deficiency].
carnitine o-palmitoyltransferase deficiency
[Clinical features and genetic analysis of a case with carnitine palmitoyltransferase 1A deficiency].
carnitine o-palmitoyltransferase deficiency
[CPT2 gene mutation analysis and prenatal diagnosis in a family with carnitine palmitoyltransferase II deficiency].
carnitine o-palmitoyltransferase deficiency
[Exercise-intolerance and exercise-induced rhabdomyolisis: etiology and diagnosis]
carnitine o-palmitoyltransferase deficiency
[Exploration of exercise intolerance by 31P NMR spectroscopy of calf muscles coupled with MRI and ergometry]
carnitine o-palmitoyltransferase deficiency
[Heterogeneity of carnitine palmitoyltransferase deficiencies. Deficiency of CPT I in the hepatic form and CPT II in the muscular form]
carnitine o-palmitoyltransferase deficiency
[Identification of missense mutations and haplotyping of carnitine palmitoyltransferase II gene]
carnitine o-palmitoyltransferase deficiency
[Intolerance to exercise caused by carnitine palmitoyltransferase deficiency]
carnitine o-palmitoyltransferase deficiency
[Lipid storage myopathies--carnitine deficiency, carnitine palmitoyltransferase deficiency, pyruvate decarboxylase deficiency]
carnitine o-palmitoyltransferase deficiency
[Molecular analysis of a patient with carnitine palmitoyltransferase II deficiency]
carnitine o-palmitoyltransferase deficiency
[Myoglobinuria and carnitine palmitoyltransferase deficiency. Diagnostic procedure and differential diagnosis]
carnitine o-palmitoyltransferase deficiency
[Myopathy due to carnitine palmitoyltransferase deficiency. Report of 2 cases with enzymatic analyses on muscle tissue]
carnitine o-palmitoyltransferase deficiency
[Myopathy in the course of carnitine palmitoyltransferase II deficiency].
carnitine o-palmitoyltransferase deficiency
[New approaches for the treatment of metabolic myopathies]
carnitine o-palmitoyltransferase deficiency
[Non-ketotic hypoglycemia caused by carnitine palmitoyl transferase 1 deficiency]
carnitine o-palmitoyltransferase deficiency
[Recurrent myoglobinuria in a girl due to carnitine palmitoyltransferase deficiency]
carnitine o-palmitoyltransferase deficiency
[Rhabdomyolysis caused by carnitine palmitoyltransferase deficiency. Prevention of acute kidney failure]
carnitine o-palmitoyltransferase deficiency
[Rhabdomyolysis caused by carnitine palmitoyltransferase deficiency]
carnitine o-palmitoyltransferase deficiency
[Rhabdomyolysis due to muscle enzyme deficiencies]
carnitine o-palmitoyltransferase deficiency
[Rhabdomyolysis in carnitine palmitoyltransferase deficiency]
carnitine o-palmitoyltransferase deficiency
[Rhabdomyolysis in carnitine palmitoyltransferase II deficiency: developments in pathophysiology, diagnosis and therapy]
carnitine o-palmitoyltransferase deficiency
[Tandem mass spectrometry analysis and genetic diagnosis of neonates with fatty acid oxidation disorders in central and northern regions of Guangxi].
carnitine o-palmitoyltransferase deficiency
[Type II carnitine palmitoyl transferase deficiency complicated by acute respiratory failure]
Cataplexy
Polymorphism located between CPT1B and CHKB, and HLA-DRB1*1501-DQB1*0602 haplotype confer susceptibility to CNS hypersomnias (essential hypersomnia).
Central Nervous System Diseases
Central nervous system disorders and possible brain type carnitine palmitoyltransferase II deficiency.
Central Nervous System Diseases
Dysregulation of metabolic pathways by carnitine palmitoyl-transferase 1 plays a key role in central nervous system disorders: experimental evidence based on animal models.
Cholestasis
Inhibition of carnitine acyltransferase activities by bile acids in rat liver peroxisomes.
Colonic Neoplasms
Dysregulated Free Fatty Acid Receptor 2 Exacerbates Colonic Adenoma Formation in Apc Min/+ Mice: Relation to Metabolism and Gut Microbiota Composition.
Colonic Neoplasms
Enhancing cancer-associated fibroblast fatty acid catabolism within a metabolically challenging tumor microenvironment drives colon cancer peritoneal metastasis.
Colonic Neoplasms
iRGD-modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation.
Colonic Neoplasms
Upregulation of CPT1A is essential for the tumor-promoting effect of adipocytes in colon cancer.
Colorectal Neoplasms
Cellular Metabolism and Dose Reveal Carnitine-Dependent and -Independent Mechanisms of Butyrate Oxidation in Colorectal Cancer Cells.
Colorectal Neoplasms
Enhancing cancer-associated fibroblast fatty acid catabolism within a metabolically challenging tumor microenvironment drives colon cancer peritoneal metastasis.
Coma
Lipids detected by brain MRS during coma caused by carnitine palmitoyltransferase 1 deficiency.
Communicable Diseases
The p.P479L variant in CPT1A is associated with infectious disease in a BC First Nation.
Compartment Syndromes
Repeat MRI in acute rhabdomyolysis: correlation with clinicopathological findings.
Confusion
Egocentric disorientation and heading disorientation: evaluation by a new test named card placing test.
Coronary Artery Disease
Carnitine palmitoyltransferase in patients with cardiac ischemia due to atherosclerotic coronary artery disease and in patients with idiopathic dilated cardiomyopathy.
COVID-19
Carnitine palmitoyltransferase II deficiency and post-COVID vaccination rhabdomyolysis.
COVID-19
Mitochondrial induced T cell apoptosis and aberrant myeloid metabolic programs define distinct immune cell subsets during acute and recovered SARS-CoV-2 infection.
Dandy-Walker Syndrome
Neonatal carnitine palmitoyltransferase II deficiency associated with Dandy-Walker syndrome and sudden death.
Deficiency Diseases
Identification by mutagenesis of a conserved glutamate (Glu487) residue important for catalytic activity in rat liver carnitine palmitoyltransferase II.
Demyelinating Diseases
Inhibition of fatty acid metabolism ameliorates disease activity in an animal model of multiple sclerosis.
Diabetes Mellitus
Alterations of heart function and Na+-K+-ATPase activity by etomoxir in diabetic rats.
Diabetes Mellitus
Carnitine palmitoyltransferase 2: analysis of membrane association and complex structure with a substrate analog.
Diabetes Mellitus
Lack of association of CPT1A polymorphisms or haplotypes on hepatic lipid content or insulin resistance in Japanese individuals with type 2 diabetes mellitus.
Diabetes Mellitus
MiRNA-324-5p inhibits inflammatory response of diabetic vessels by targeting CPT1A.
Diabetes Mellitus
Mitochondrial regulators of fatty acid metabolism reflect metabolic dysfunction in type 2 diabetes mellitus.
Diabetes Mellitus
Possible new therapeutic approach in diabetes mellitus by inhibition of carnitine palmitoyltransferase 1 (CPT1).
Diabetes Mellitus
The crystal structure of carnitine palmitoyltransferase 2 and implications for diabetes treatment.
Diabetes Mellitus, Type 2
AMPK in the small intestine in normal and pathophysiological conditions.
Diabetes Mellitus, Type 2
Aqueous-Methanol Extracts of Orange-Fleshed Sweet Potato (Ipomoeabatatas) Ameliorate Oxidative Stress and Modulate Type 2 Diabetes Associated Genes in Insulin Resistant C2C12 Cells.
Diabetes Mellitus, Type 2
C75 [4-methylene-2-octyl-5-oxo-tetrahydro-furan-3-carboxylic acid] activates carnitine palmitoyltransferase-1 in isolated mitochondria and intact cells without displacement of bound malonyl CoA.
Diabetes Mellitus, Type 2
Carnitine palmitoyltransferase 2: analysis of membrane association and complex structure with a substrate analog.
Diabetes Mellitus, Type 2
Enhanced fatty acid oxidation in adipocytes and macrophages reduces lipid-induced triglyceride accumulation and inflammation.
Diabetes Mellitus, Type 2
Fatty Acid Metabolites Combine with Reduced ? Oxidation to Activate Th17 Inflammation in Human Type 2 Diabetes.
Diabetes Mellitus, Type 2
Inhibition by etomoxir of carnitine palmitoyltransferase I reduces hepatic glucose production and plasma lipids in non-insulin-dependent diabetes mellitus.
Diabetes Mellitus, Type 2
Lack of association of CPT1A polymorphisms or haplotypes on hepatic lipid content or insulin resistance in Japanese individuals with type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
MiRNA-324-5p inhibits inflammatory response of diabetic vessels by targeting CPT1A.
Diabetes Mellitus, Type 2
Mitochondrial regulators of fatty acid metabolism reflect metabolic dysfunction in type 2 diabetes mellitus.
Diabetes, Gestational
Association of CPT1A gene polymorphism with the risk of gestational diabetes mellitus: a case-control study.
Diabetic Cardiomyopathies
[Screening and analysis of early cardiopathology-related gene in type 2 diabetes mellitus]
Diabetic Ketoacidosis
Hepatic mitochondrial function in ketogenic states. Diabetes, starvation, and after growth hormone administration.
Diabetic Nephropathies
Mitochondrial carnitine palmitoyltransferase 2 is involved in N?-(carboxymethyl)-lysine-mediated diabetic nephropathy.
Disorders of Excessive Somnolence
Polymorphism located between CPT1B and CHKB, and HLA-DRB1*1501-DQB1*0602 haplotype confer susceptibility to CNS hypersomnias (essential hypersomnia).
Dyslipidemias
Effect of pigeon pea (Cajanus cajan L.) on high-fat diet-induced hypercholesterolemia in hamsters.
Dyslipidemias
Preventive effect of small-leaved Kuding tea (Ligustrum robustum) on high-diet-induced obesity in C57BL/6J mice.
Encephalitis
Association of CPT II gene with risk of acute encephalitis in Chinese children.
Encephalitis
Association of the Polymorphism of rs1799822 on Carnitine Palmitoyltransferase II Gene with Severe Enterovirus 71 Encephalitis in Chinese Children.
Encephalitis
Pharmacological inhibition of carnitine palmitoyl transferase 1 inhibits and reverses experimental autoimmune encephalitis in rodents.
Encephalomyelitis
CPT1A plays a key role in the development and treatment of multiple sclerosis and experimental autoimmune encephalomyelitis.
Encephalomyelitis, Autoimmune, Experimental
CPT1A plays a key role in the development and treatment of multiple sclerosis and experimental autoimmune encephalomyelitis.
Endotoxemia
Differential effects of neonatal endotoxemia on heart and kidney carnitine palmitoyl transferase I.
Epilepsy
Association of CYP2C9, CYP2A6, ACSM2A, and CPT1A gene polymorphisms with adverse effects of valproic acid in Chinese patients with epilepsy.
Epilepsy
[Analysis of a child with carnitine palmitoyl transferase 1A deficiency due to variant of CPT1A gene].
Epstein-Barr Virus Infections
Repeat MRI in acute rhabdomyolysis: correlation with clinicopathological findings.
Fatigue Syndrome, Chronic
Long-chain acylcarnitine deficiency in patients with chronic fatigue syndrome. Potential involvement of altered carnitine palmitoyltransferase-I activity.
Fatty Liver
A common haplotype of carnitine palmitoyltransferase 1b is associated with the metabolic syndrome.
Fatty Liver
A patient with atypical presentation of chronic hepatosteatosis and developmental delay harboring a novel variant in the CPT1A gene.
Fatty Liver
Adaptations of hepatic lipid metabolism and mitochondria in dairy cows with mild fatty liver.
Fatty Liver
Altered expression of carnitine palmitoyltransferase II in liver, muscle, and heart of mouse strain with juvenile visceral steatosis.
Fatty Liver
Ananas comosus L. Leaf Phenols and p-Coumaric Acid Regulate Liver Fat Metabolism by Upregulating CPT-1 Expression.
Fatty Liver
Are miRNA-103, miRNA-107 and miRNA-122 Involved in the Prevention of Liver Steatosis Induced by Resveratrol?
Fatty Liver
Changes in hepatic lipogenic and oxidative enzymes and glucose homeostasis induced by an acetyl-l-carnitine and nicotinamide treatment in dyslipidaemic insulin-resistant rats.
Fatty Liver
Chinese medicine formula lingguizhugan decoction improves Beta-oxidation and metabolism of Fatty Acid in high-fat-diet-induced rat model of Fatty liver disease.
Fatty Liver
Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice.
Fatty Liver
Cyclooxygenase inhibition upregulates liver carnitine palmitoyltransferase 1A (CPT1A) expression and improves fatty liver.
Fatty Liver
Effect of methotrexate on long-chain fatty acid metabolism in liver of rats fed a standard or a defined, choline-deficient diet.
Fatty Liver
Effects of post-suckling n-3 polyunsaturated fatty acids: prevention of dyslipidemia and liver steatosis induced in rats by a sucrose-rich diet during pre- and post-natal life.
Fatty Liver
Increased expression of carnitine palmitoyltransferase I gene is repressed by administering L-carnitine in the hearts of carnitine-deficient juvenile visceral steatosis mice.
Fatty Liver
Inhibition of Carnitine Palmitoyltransferase 1A Aggravates Fatty Liver Graft Injury via Promoting Mitochondrial Permeability Transition.
Fatty Liver
Inhibitory effect of Ginkgo biloba extract on fatty liver: Regulation of carnitine palmitoyltransferase 1a and fatty acid metabolism.
Fatty Liver
Involvement of adenosine monophosphate-activated protein kinase in the influence of timed high-fat evening diet on the hepatic clock and lipogenic gene expression in mice.
Fatty Liver
Lack of association of CPT1A polymorphisms or haplotypes on hepatic lipid content or insulin resistance in Japanese individuals with type 2 diabetes mellitus.
Fatty Liver
Liver-specific deletion of IGF2 mRNA binding protein-2/IMP2 reduces hepatic fatty acid oxidation and increases hepatic triglyceride accumulation.
Fatty Liver
Low abundance of mitofusin 2 in dairy cows with moderate fatty liver is associated with alterations in hepatic lipid metabolism.
Fatty Liver
Platycodon grandiflorum-derived saponin enhances exercise function, skeletal muscle protein synthesis, and mitochondrial function.
Fatty Liver
Preliminary studies on hepatic carnitine palmitoyltransferase in dairy cattle with or without fatty liver.
Follicular Cyst
Alterations in key metabolic sensors involved in bovine cystic ovarian disease.
Gastroenteritis
Association of the CPT1A p.P479L Metabolic Gene Variant With Childhood Respiratory and Other Infectious Illness in Nunavut.
Gastrointestinal Neoplasms
Inhibition of fatty acid catabolism augments the efficacy of oxaliplatin-based chemotherapy in gastrointestinal cancers.
Glioblastoma
High grade glioblastoma is associated with aberrant expression of ZFP57, a protein involved in gene imprinting, and of CPT1A and CPT1C that regulate fatty acid metabolism.
Glioblastoma
Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells.
Glioblastoma
Very long chain fatty acid ?-oxidation in astrocytes: contribution of the ABCD1-dependent and -independent pathways.
Glioma
Elevated expression of fatty acid synthase and nuclear localization of carnitine palmitoyltransferase 1C are common among human gliomas.
Glioma
Impact of mitochondrial beta-oxidation in fatty acid-mediated inhibition of glioma cell proliferation.
Glioma
Inhibition of Metabolic Shift can Decrease Therapy Resistance in Human High-Grade Glioma Cells.
Glioma
Poly-ion complex micelles effectively deliver CoA-conjugated CPT1A inhibitors to modulate lipid metabolism in brain cells.
Glucose Intolerance
Enhanced susceptibility of Cpt1c knockout mice to glucose intolerance induced by a high-fat diet involves elevated hepatic gluconeogenesis and decreased skeletal muscle glucose uptake.
Glucose Intolerance
Glucometabolic consequences of acute and prolonged inhibition of fatty acid oxidation.
glycogen phosphorylase deficiency
Recurrent rhabdomyolysis in a collegiate athlete: a case report.
Glycogen Storage Disease
Glycerolphosphate acyltransferase, dihydroxyacetonephosphate acyltransferase and carnitine palmitoyltransferase in a glycogen storage disease (gsd/gsd) rat.
Glycogen Storage Disease
Therapeutic advances in the management of Pompe disease and other metabolic myopathies.
Glycogen Storage Disease Type II
Therapeutic advances in the management of Pompe disease and other metabolic myopathies.
Glycogen Storage Disease Type V
Carnitine palmitoyltransferase deficiency in a college athlete: a case report and literature review.
Glycogen Storage Disease Type V
Genetic risk factors associated with lipid-lowering drug-induced myopathies.
Glycogen Storage Disease Type V
Recurrent rhabdomyolysis in a collegiate athlete: a case report.
Glycogen Storage Disease Type VII
Abnormal oxidative metabolism and O2 transport in muscle phosphofructokinase deficiency.
Heart Failure
Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure.
Heart Failure
Carnitine Palmitoyltransferase-1b (CPT1b) Deficiency Aggravates Pressure-Overload-Induced Cardiac Hypertrophy due to Lipotoxicity.
Heart Failure
Carnitine palmitoyltransferase-I, a new target for the treatment of heart failure: perspectives on a shift in myocardial metabolism as a therapeutic intervention.
Heart Failure
Effect of Allopurinol on Myocardial Energy Metabolism in Chronic Heart Failure Rats After Myocardial Infarct.
Heart Failure
Improving characterization of hypertrophy-induced murine cardiac dysfunction using four-dimensional ultrasound-derived strain mapping.
Heart Failure
Metoprolol represses PGC1alpha-mediated carnitine palmitoyltransferase-1B expression in the diabetic heart.
Heart Failure
Myocardial carnitine and carnitine palmitoyltransferase deficiencies in patients with severe heart failure.
Heart Failure
Sarcoplasmic reticulum function and carnitine palmitoyltransferase-1 inhibition during progression of heart failure.
Heart Failure
The metabolic modulators, Etomoxir and NVP-LAB121, fail to reverse pressure overload induced heart failure in vivo.
Hematologic Diseases
Inhibition of CPT1a as a prognostic marker can synergistically enhance the antileukemic activity of ABT199.
Hematologic Neoplasms
Targeting the leukemia cell metabolism by the CPT1a inhibition: functional preclinical effects in leukemias.
Hepatic Encephalopathy
A patient with atypical presentation of chronic hepatosteatosis and developmental delay harboring a novel variant in the CPT1A gene.
Hepatic Encephalopathy
Carnitine palmitoyltransferase 1A (CPT1A) P479L prevalence in live newborns in Yukon, Northwest Territories, and Nunavut.
Hepatic Encephalopathy
Novel mutation in carnitine palmitoyltransferase 1A detected through newborn screening for a presymptomatic case in China: a case report.
Hepatic Encephalopathy
Novel Mutations in the CPT1A Gene Identified in the Patient Presenting Jaundice as the First Manifestation of Carnitine Palmitoyltransferase 1A Deficiency.
Hepatic Encephalopathy
Postoperative coma in a child with carnitine palmitoyltransferase I deficiency.
Hepatitis
Carnitine palmitoyl transferase 1A deficiency in an adult with recurrent severe steato hepatitis aggravated by high pathologic or physiologic demands: A roller-coaster for internists.
Hepatitis C
Hepatitis C virus infection down-regulates the expression of peroxisome proliferator-activated receptor alpha and carnitine palmitoyl acyl-CoA transferase 1A.
Hepatomegaly
Cholestatic Jaundice Associated with Carnitine Palmitoyltransferase IA Deficiency.
Hepatomegaly
Novel metabolic and molecular findings in hepatic carnitine palmitoyltransferase I deficiency.
Hepatomegaly
The hypolipidemic peroxisome-proliferating drug, bis(carboxymethylthio)-1.10 decane, a dicarboxylic metabolite of tiadenol, is activated to an acylcoenzyme A thioester.
Homocystinuria
Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: a four-year report.
Homocystinuria
Targeted metabolomic analysis of plasma samples for the diagnosis of inherited metabolic disorders.
hydroxymethylglutaryl-coa lyase deficiency
Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: a four-year report.
Hyperargininemia
Targeted metabolomic analysis of plasma samples for the diagnosis of inherited metabolic disorders.
Hypercholesterolemia
Hypercholesterolemia treatment in a patient with family hypercholesterolemia and myopathy due to carnitine palmitoyltransferase II deficiency with PCSK9 inhibitors.
Hyperglycemia
Malonyl coenzyme A and the regulation of functional carnitine palmitoyltransferase-1 activity and fat oxidation in human skeletal muscle.
Hyperglycemia
Paeoniflorin Protects against Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet in Mice.
Hyperinsulinism
Hypoglycemia but not hyperglycemia induces rapid changes in pancreatic beta-cell gene transcription.
Hyperinsulinism
Malonyl coenzyme A and the regulation of functional carnitine palmitoyltransferase-1 activity and fat oxidation in human skeletal muscle.
Hyperlipidemias
Curcumin attenuates ethanol-induced hepatic steatosis through modulating Nrf2/FXR signaling in hepatocytes.
Hyperlipidemias
Paeoniflorin Protects against Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet in Mice.
Hyperlipidemias
[Study on effect of berberine on modulating lipid and CPT I A gene expression].
Hyperparathyroidism
Secondary carnitine palmitoyltransferase deficiency in chronic renal failure and secondary hyperparathyroidism.
Hyperparathyroidism, Secondary
A case of partial carnitine palmitoyltransferase deficiency in a patient undergoing chronic hemodialysis.
Hyperparathyroidism, Secondary
Secondary carnitine palmitoyltransferase deficiency in chronic renal failure and secondary hyperparathyroidism.
Hypersensitivity
Mutations of the withered (whd) gene in Drosophila melanogaster confer hypersensitivity to oxidative stress and are lesions of the carnitine palmitoyltransferase I (CPT I) gene.
Hypertension
Niacin improves renal lipid metabolism and slows progression in chronic kidney disease.
Hyperthyroidism
A thyroid hormone response unit formed between the promoter and first intron of the carnitine palmitoyltransferase-Ialpha gene mediates the liver-specific induction by thyroid hormone.
Hyperthyroidism
Carnitine palmitoyltransferase: activation and inactivation in liver mitochondria from fed, fasted, hypo- and hyperthyroid rats.
Hyperthyroidism
Changes in carnitine palmitoyltransferase-I mRNA abundance produced by hyperthyroidism and hypothyroidism parallel changes in activity.
Hyperthyroidism
Differential influences of carnitine palmitoyltransferase-1 inhibition and hyperthyroidism on cardiac growth and sarcoplasmic reticulum phosphorylation.
Hyperthyroidism
Expression and activity of lipid and oxidative metabolism enzymes following elevated temperature exposure and thyroid hormone manipulation in juvenile lake whitefish (Coregonus clupeaformis).
Hyperthyroidism
Hyperthyroidism facilitates cardiac fatty acid oxidation through altered regulation of cardiac carnitine palmitoyltransferase: studies in vivo and with cardiac myocytes.
Hyperthyroidism
The outer carnitine palmitoyltransferase and regulation of fatty acid metabolism in rat liver in different thyroid states.
Hyperthyroidism
The relationship between fat synthesis and oxidation in the liver after re-feeding and its regulation by thyroid hormone.
Hyperthyroidism
Thyroid hormone regulates carnitine palmitoyltransferase Ialpha gene expression through elements in the promoter and first intron.
Hypertriglyceridemia
Effects of post-suckling n-3 polyunsaturated fatty acids: prevention of dyslipidemia and liver steatosis induced in rats by a sucrose-rich diet during pre- and post-natal life.
Hypertriglyceridemia
Reversal of obesity-induced hypertriglyceridemia by (R)-?-lipoic acid in ZDF (fa/fa) rats.
Hypoglycemia
A patient with atypical presentation of chronic hepatosteatosis and developmental delay harboring a novel variant in the CPT1A gene.
Hypoglycemia
Abnormal CpG island methylation occurs during in vitro differentiation of human embryonic stem cells.
Hypoglycemia
Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects.
Hypoglycemia
Functional and structural basis of carnitine palmitoyltransferase 1A deficiency.
Hypoglycemia
Hypoglycemia but not hyperglycemia induces rapid changes in pancreatic beta-cell gene transcription.
Hypoglycemia
Hypothalamic Regulation of Liver and Muscle Nutrient Partitioning by Brain-Specific Carnitine Palmitoyltransferase 1C in Male Mice.
Hypoglycemia
Impaired fasting tolerance among Alaska native children with a common carnitine palmitoyltransferase 1A sequence variant.
Hypoglycemia
Infantile form of carnitine palmitoyltransferase II deficiency with hepatomuscular symptoms and sudden death. Physiopathological approach to carnitine palmitoyltransferase II deficiencies.
Hypoglycemia
Lethal neonatal and severe late infantile forms of carnitine palmitoyltransferase II deficiency associated with compound heterozygosity for different protein truncation mutations.
Hypoglycemia
Naloxone, but not valsartan, preserves responses to hypoglycemia after antecedent hypoglycemia: Role of metabolic reprogramming in counterregulatory failure.
Hypoglycemia
Neonatal hypoglycemia and the CPT1A P479L variant in term newborns: A retrospective cohort study of Inuit newborns from Kivalliq Nunavut.
Hypoglycemia
Normal muscle CPT1 and CPT2 activities in hepatic presentation patients with CPT1 deficiency in fibroblasts. Tissue specific isoforms of CPT1?
Hypoglycemia
Novel metabolic and molecular findings in hepatic carnitine palmitoyltransferase I deficiency.
Hypoglycemia
Novel mutation in carnitine palmitoyltransferase 1A detected through newborn screening for a presymptomatic case in China: a case report.
Hypoglycemia
Novel Mutations in the CPT1A Gene Identified in the Patient Presenting Jaundice as the First Manifestation of Carnitine Palmitoyltransferase 1A Deficiency.
Hypoglycemia
Severe rhabdomyolysis with hypoglycemia in an adult patient with carnitine palmitoyltransferase II deficiency.
Hypoglycemia
The role of chicken ovalbumin upstream promoter transcription factor II in the regulation of hepatic fatty acid oxidation and gluconeogenesis in newborn mice.
Hypoglycemia
[Non-ketotic hypoglycemia caused by carnitine palmitoyl transferase 1 deficiency]
Hypothyroidism
Carnitine palmitoyltransferase in liver and five extrahepatic tissues in the rat. Inhibition by DL-2-bromopalmitoyl-CoA and effect of hypothyroidism.
Hypothyroidism
Changes in carnitine palmitoyltransferase-I mRNA abundance produced by hyperthyroidism and hypothyroidism parallel changes in activity.
Hypothyroidism
Gestational hypothyroidism elicits more pronounced lipid dysregulation in mice than pre-pregnant hypothyroidism.
Hypothyroidism
Triiodothyronine induces lipid oxidation and mitochondrial biogenesis in rat Harderian gland.
Ichthyosis
High frequency of ETFDH c.250G>A mutation in Taiwanese patients with late-onset lipid storage myopathy.
Infections
Acute severe encephalopathy related to human herpesvirus-6 infection in a patient with carnitine palmitoyltransferase 2 deficiency carrying thermolabile variants.
Infections
Association of a Genetic Variant of Carnitine Palmitoyltransferase 1A with Infections in Alaska Native Children.
Infections
Carnitine palmitoyl transferase II deficiency in an adolescent presenting with rhabdomyolysis and acute renal failure.
Infections
Carnitine palmitoyl transferase II polymorphism is associated with multiple syndromes of acute encephalopathy with various infectious diseases.
Infections
Carnitine Palmitoyltransferase 1 Increases Lipolysis, UCP1 Protein Expression and Mitochondrial Activity in Brown Adipocytes.
Infections
Enhanced fatty acid oxidation in adipocytes and macrophages reduces lipid-induced triglyceride accumulation and inflammation.
Infections
Expression analysis of genes related to lipid metabolism in peripheral blood lymphocytes of chickens challenged with reticuloendotheliosis virus.
Infections
Hepatitis C virus infection down-regulates the expression of peroxisome proliferator-activated receptor alpha and carnitine palmitoyl acyl-CoA transferase 1A.
Infections
Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection.
Infections
Muscle Carnitine Palmitoyltransferase II Deficiency: A Review of Enzymatic Controversy and Clinical Features.
Infections
Pandemic influenza A-associated acute necrotizing encephalopathy without neurologic sequelae.
Infections
Rhabdomyolysis and respiratory failure: rare presentation of carnitine palmityl-transferase II deficiency.
Inflammatory Bowel Diseases
Quiescent Endothelial Cells Upregulate Fatty Acid ?-Oxidation for Vasculoprotection via Redox Homeostasis.
Influenza, Human
Pandemic influenza A-associated acute necrotizing encephalopathy without neurologic sequelae.
Insulin Resistance
Age-related susceptibility to insulin resistance arises from a combination of CPT1B decline and lipid overload.
Insulin Resistance
AMPK in the small intestine in normal and pathophysiological conditions.
Insulin Resistance
Brain neuropeptide Y and CCK and peripheral adipokine receptors: temporal response in obesity induced by palatable diet.
Insulin Resistance
Carnitine Palmitoyltransferase 1b Deficiency Protects Mice from Diet-Induced Insulin Resistance.
Insulin Resistance
Carnitine Palmitoyltransferase 1b Deficient Mice Develop Severe Insulin Resistance After Prolonged High Fat Diet Feeding.
Insulin Resistance
Carnitine palmitoyltransferase 2 knockout potentiates palmitate-induced insulin resistance in C2C12 myotubes.
Insulin Resistance
Carnitine palmitoyltransferase-1A prevents free fatty acid induced adipocyte dysfunction through suppression of c-Jun N-terminal kinase.
Insulin Resistance
CPT I overexpression protects L6E9 muscle cells from fatty acid-induced insulin resistance.
Insulin Resistance
Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis.
Insulin Resistance
Diet Consisting of Balanced Yogurt, Fruit, and Vegetables Modifies the Gut Microbiota and Protects Mice against Nonalcoholic Fatty Liver Disease.
Insulin Resistance
Enhanced susceptibility of Cpt1c knockout mice to glucose intolerance induced by a high-fat diet involves elevated hepatic gluconeogenesis and decreased skeletal muscle glucose uptake.
Insulin Resistance
Exercise Training Improves Whole Body Insulin Resistance via Adiponectin Receptor 1.
Insulin Resistance
Exercise training-induced improvement in skeletal muscle PGC-1?-mediated fat metabolism is independent of dietary glycemic index.
Insulin Resistance
High-intensity exercise to promote accelerated improvements in cardiorespiratory fitness (HI-PACE): study protocol for a randomized controlled trial.
Insulin Resistance
Human skeletal muscle PPARalpha expression correlates with fat metabolism gene expression but not BMI or insulin sensitivity.
Insulin Resistance
Increased reactive oxygen species production and lower abundance of complex I subunits and carnitine palmitoyltransferase 1B protein despite normal mitochondrial respiration in insulin-resistant human skeletal muscle.
Insulin Resistance
Influence of the carnitine palmitoyltransferase inhibitor POCA on myocardial performance and metabolism of insulin resistant rats.
Insulin Resistance
Inhibition of carnitine palmitoyltransferase 1 by phenylalkyloxiranecarboxylic acid and its influence on lipolysis and glucose metabolism in isolated, perfused hearts of streptozotocin-diabetic rats.
Insulin Resistance
Inhibition of carnitine palmitoyltransferase-1 activity alleviates insulin resistance in diet-induced obese mice.
Insulin Resistance
Inhibition of carnitine palymitoyltransferase1b induces cardiac hypertrophy and mortality in mice.
Insulin Resistance
Intramuscular Injection of miR-1 Reduces Insulin Resistance in Obese Mice.
Insulin Resistance
Isolated compounds from Cuscuta pedicellata ameliorate oxidative stress and upregulate expression of some energy regulatory genes in high fat diet induced obesity in rats.
Insulin Resistance
Lack of association of CPT1A polymorphisms or haplotypes on hepatic lipid content or insulin resistance in Japanese individuals with type 2 diabetes mellitus.
Insulin Resistance
Loss of Muscle Carnitine Palmitoyltransferase 2 Prevents Diet-Induced Obesity and Insulin Resistance despite Long-Chain Acylcarnitine Accumulation.
Insulin Resistance
Metabolic characterization of a woman homozygous for the Ser113Leu missense mutation in carnitine palmitoyl transferase II.
Insulin Resistance
Muscle expression of a malonyl-CoA-insensitive carnitine palmitoyltransferase-1 protects mice against high-fat/high-sucrose diet-induced insulin resistance.
Insulin Resistance
Obesity-alleviating potential of asiatic acid and its effects on ACC1, UCP2, and CPT1 mRNA expression in high fat diet-induced obese Sprague-Dawley rats.
Insulin Resistance
Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance.
Insulin Resistance
Palmitate-induced skeletal muscle insulin resistance does not require NF-kappaB activation.
Insulin Resistance
Pathophysiology of type 2 diabetes and modes of action of therapeutic interventions.
Insulin Resistance
Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in rats.
Insulin Resistance
Resveratrol improves high fat diet-induced fatty liver and insulin resistance by concomitant inhibiting proteolytic cleavage of SREBPS , FFAs oxidation, and intestinal TGS absorption.
Insulin Resistance
Resveratrol prevents the wasting disorders of mechanical unloading by acting as a physical exercise mimetic in the rat.
Insulin Resistance
Rosiglitazone reduces fatty acid translocase and increases AMPK in skeletal muscle in aged rats: a possible mechanism to prevent high-fat-induced insulin resistance.
Insulin Resistance
Skeletal muscle-specific CPT1 deficiency elevates lipotoxic intermediates but preserves insulin sensitivity.
Insulin Resistance
SUMO-Specific Protease 2 (SENP2) Is an Important Regulator of Fatty Acid Metabolism in Skeletal Muscle.
Insulin Resistance
The hepatokine FGF21 is crucial for peroxisome proliferator-activated receptor-? agonist-induced amelioration of metabolic disorders in obese mice.
Insulin Resistance
The PPARdelta agonist, GW501516, promotes fatty acid oxidation but has no direct effect on glucose utilisation or insulin sensitivity in rat L6 skeletal muscle cells.
Insulin Resistance
Upregulation of peroxisome proliferator-activated receptor gamma coactivator gene (PGC1A) during weight loss is related to insulin sensitivity but not to energy expenditure.
Insulin Resistance
[Effects of fenofibrate on gene expression of carnitine palmitoyltransferase 1 in liver and skeletal muscle and its influence on insulin sensitivity]
Insulinoma
The Interplay of Prolactin and the Glucocorticoids in the Regulation of {beta}-Cell Gene Expression, Fatty Acid Oxidation, and Glucose-Stimulated Insulin Secretion: Implications for Carbohydrate Metabolism in Pregnancy.
Intellectual Disability
Attention remediation following traumatic brain injury in childhood and adolescence.
Ketosis
Carnitine palmitoyltransferase I in liver of periparturient dairy cows: effects of prepartum intake, postpartum induction of ketosis, and periparturient disorders.
Ketosis
Role of carnitine palmitoyltransferase I in the regulation of hepatic ketogenesis during the onset and reversal of chronic diabetes.
Ketosis
The role of changes in the sensitivity of hepatic mitochondrial overt carnitine palmitoyltransferase in determining the onset of the ketosis of starvation in the rat.
Kidney Failure, Chronic
Secondary carnitine palmitoyltransferase deficiency in chronic renal failure and secondary hyperparathyroidism.
Kidney Neoplasms
Identification of CPT1A as a Prognostic Biomarker and Potential Therapeutic Target for Kidney Renal Clear Cell Carcinoma and Establishment of a Risk Signature of CPT1A-Related Genes.
Leukemia
High Expression of CPT1A Predicts Adverse Outcomes: A Potential Therapeutic Target for Acute Myeloid Leukemia.
Leukemia
Targeting the leukemia cell metabolism by the CPT1a inhibition: functional preclinical effects in leukemias.
Leukemia, Lymphocytic, Chronic, B-Cell
A reversible carnitine palmitoyltransferase (CPT1) inhibitor offsets the proliferation of chronic lymphocytic leukemia cells.
Leukemia, Myeloid, Acute
High Expression of CPT1A Predicts Adverse Outcomes: A Potential Therapeutic Target for Acute Myeloid Leukemia.
Leukemia, Myeloid, Acute
Inhibition of CPT1a as a prognostic marker can synergistically enhance the antileukemic activity of ABT199.
Lipidoses
Hepatic gene expression changes in mouse models with liver-specific deletion or global suppression of the NADPH-cytochrome P450 reductase gene. Mechanistic implications for the regulation of microsomal cytochrome P450 and the fatty liver phenotype.
Liver Cirrhosis
A patient with atypical presentation of chronic hepatosteatosis and developmental delay harboring a novel variant in the CPT1A gene.
Liver Cirrhosis
Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma.
Liver Cirrhosis
The water extract of Sophorae tonkinensis Radix et Rhizoma alleviates non-alcoholic fatty liver disease and its mechanism.
Liver Diseases
?-Tocopherol suppresses hepatic steatosis by increasing CPT-1 expression in a mouse model of diet-induced nonalcoholic fatty liver disease.
Liver Diseases
Activation of the Peroxisome Proliferator-Activated Receptors (PPAR-?/?) and the Fatty Acid Metabolizing Enzyme Protein CPT1A by Camel Milk Treatment Counteracts the High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease.
Liver Diseases
Alogliptin alleviates hepatic steatosis in a mouse model of nonalcoholic fatty liver disease by promoting CPT1a expression via Thr172 phosphorylation of AMPK? in the liver.
Liver Diseases
Ananas comosus L. Leaf Phenols and p-Coumaric Acid Regulate Liver Fat Metabolism by Upregulating CPT-1 Expression.
Liver Diseases
Association of CYP2C9, CYP2A6, ACSM2A, and CPT1A gene polymorphisms with adverse effects of valproic acid in Chinese patients with epilepsy.
Liver Diseases
Chinese medicine formula lingguizhugan decoction improves Beta-oxidation and metabolism of Fatty Acid in high-fat-diet-induced rat model of Fatty liver disease.
Liver Diseases
Cholestatic Jaundice Associated with Carnitine Palmitoyltransferase IA Deficiency.
Liver Diseases
n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Liver Diseases
TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation.
Liver Diseases
[Effect of chitooligosaccharide on hepatic triglyceride metabolism and related mechanisms].
Liver Diseases, Alcoholic
n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Liver Failure
Clinical and genetic characteristics of patients with fatty acid oxidation disorders identified by newborn screening.
long-chain acyl-coa dehydrogenase deficiency
Clinical and genetic characteristics of patients with fatty acid oxidation disorders identified by newborn screening.
long-chain acyl-coa dehydrogenase deficiency
Diagnostic assessment and long-term follow-up of 13 patients with Very Long-Chain Acyl-Coenzyme A dehydrogenase (VLCAD) deficiency.
long-chain acyl-coa dehydrogenase deficiency
Fatty Acid oxidation disorders in a chinese population in taiwan.
long-chain acyl-coa dehydrogenase deficiency
Follow-up of fatty acid ?-oxidation disorders in expanded newborn screening era.
long-chain acyl-coa dehydrogenase deficiency
No effect of bezafibrate in patients with CPTII and VLCAD deficiencies.
long-chain acyl-coa dehydrogenase deficiency
Rhabdomyolysis with different etiologies in childhood.
long-chain acyl-coa dehydrogenase deficiency
Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: a four-year report.
long-chain acyl-coa dehydrogenase deficiency
Subclinical effects of long-chain fatty acid ?-oxidation deficiency on the adult heart: A case-control magnetic resonance study.
long-chain acyl-coa dehydrogenase deficiency
[Application of tandem mass spectrometry on the diagnosis of fatty acid oxidation disorders]
long-chain-3-hydroxyacyl-coa dehydrogenase deficiency
Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts.
long-chain-3-hydroxyacyl-coa dehydrogenase deficiency
Subclinical effects of long-chain fatty acid ?-oxidation deficiency on the adult heart: A case-control magnetic resonance study.
Lymphatic Metastasis
Inhibition of carnitine palmitoyl transferase 1A-induced fatty acid oxidation suppresses cell progression in gastric cancer.
Malnutrition
Impact of protein restriction on the regulation of cardiac carnitine palmitoyltransferase by malonyl-CoA.
Malnutrition
Increased L-CPT-1 activity and altered gene expression in pancreatic islets of malnourished adult rats: a possible relationship between elevated free fatty acid levels and impaired insulin secretion.
Malnutrition
Pre- and postnatal protein undernutrition increases hepatic carnitine palmitoyltransferase I activity and decreases enzyme sensitivity to inhibitors in the suckling rat.
Malnutrition
Undernutrition during suckling in rats elevates plasma adiponectin and its receptor in skeletal muscle regardless of diet composition: a protective effect?
Maple Syrup Urine Disease
Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: a four-year report.
Maple Syrup Urine Disease
Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program.
Maple Syrup Urine Disease
Targeted metabolomic analysis of plasma samples for the diagnosis of inherited metabolic disorders.
medium-chain acyl-coa dehydrogenase deficiency
Fatty Acid oxidation disorders in a chinese population in taiwan.
medium-chain acyl-coa dehydrogenase deficiency
Follow-up of fatty acid ?-oxidation disorders in expanded newborn screening era.
medium-chain acyl-coa dehydrogenase deficiency
In vivo stable isotope studies in three patients affected with mitochondrial fatty acid oxidation disorders: limited diagnostic use of 1-13C fatty acid breath test using bolus technique.
medium-chain acyl-coa dehydrogenase deficiency
Selective screening for fatty acid oxidation disorders by tandem mass spectrometry: difficulties in practical discrimination.
medium-chain acyl-coa dehydrogenase deficiency
Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: a four-year report.
medium-chain acyl-coa dehydrogenase deficiency
Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program.
medium-chain acyl-coa dehydrogenase deficiency
[Application of tandem mass spectrometry on the diagnosis of fatty acid oxidation disorders]
medium-chain acyl-coa dehydrogenase deficiency
[Tandem mass spectrometry analysis and genetic diagnosis of neonates with fatty acid oxidation disorders in central and northern regions of Guangxi].
Melanoma
A fatty acid oxidation-dependent metabolic shift regulates the adaptation of BRAF-mutated melanoma to MAPK inhibitors.
Melanoma
Silencing of Peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas.
Melanoma
Targeting CPT1A enhances metabolic therapy in human melanoma cells with the BRAF V600E mutation.
Memory Disorders
PPAR?/?-agonist GW0742 ameliorates dysfunction in fatty acid oxidation in PSEN1?E9 astrocytes.
Metabolic Diseases
Carbohydrate and fat intake associated with risk of metabolic diseases through epigenetics of CPT1A.
Metabolic Diseases
Cystic renal dysplasia as a leading sign of inherited metabolic disease.
Metabolic Diseases
Establishing a relationship between prolactin and altered fatty acid ?-oxidation via carnitine palmitoyl transferase 1 in breast cancer cells.
Metabolic Diseases
[Alterations of mitochondria in metabolic diseases. Carnitine deficiency, carnitine palmitoyltransferase deficiency and beta oxidation.]
Metabolic Syndrome
A common haplotype of carnitine palmitoyltransferase 1b is associated with the metabolic syndrome.
Metabolic Syndrome
Association of DNA Methylation at CPT1A Locus with Metabolic Syndrome in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) Study.
Metabolic Syndrome
Genome- and epigenome-wide association study of hypertriglyceridemic waist in Mexican American families.
Metabolic Syndrome
Metabolic effects of RUBCN/Rubicon deficiency in kidney proximal tubular epithelial cells.
methylcrotonoyl-coa carboxylase deficiency
Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: a four-year report.
methylcrotonoyl-coa carboxylase deficiency
Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program.
Mitochondrial Myopathies
[Exploration of exercise intolerance by 31P NMR spectroscopy of calf muscles coupled with MRI and ergometry]
Multicystic Dysplastic Kidney
SEVERE INFANTILE CARNITINE PALMITOYLTRANSFERASE II (CPT II) DEFICIENCY IN 19-WEEK FETAL SIBS.
Multiple Acyl Coenzyme A Dehydrogenase Deficiency
A survey of Japanese patients with mitochondrial fatty acid beta-oxidation and related disorders as detected from 1985 to 2000.
Multiple Acyl Coenzyme A Dehydrogenase Deficiency
Cystic renal dysplasia as a leading sign of inherited metabolic disease.
Multiple Acyl Coenzyme A Dehydrogenase Deficiency
Disorders of fatty acid oxidation and autosomal recessive polycystic kidney disease-different clinical entities and comparable perinatal renal abnormalities.
Multiple Acyl Coenzyme A Dehydrogenase Deficiency
Fatty Acid oxidation disorders in a chinese population in taiwan.
Multiple Acyl Coenzyme A Dehydrogenase Deficiency
Follow-up of fatty acid ?-oxidation disorders in expanded newborn screening era.
Multiple Acyl Coenzyme A Dehydrogenase Deficiency
In vivo stable isotope studies in three patients affected with mitochondrial fatty acid oxidation disorders: limited diagnostic use of 1-13C fatty acid breath test using bolus technique.
Multiple Acyl Coenzyme A Dehydrogenase Deficiency
Lethal neonatal deficiency of carnitine palmitoyltransferase II associated with dysgenesis of the brain and kidneys.
Multiple Acyl Coenzyme A Dehydrogenase Deficiency
Therapeutic advances in the management of Pompe disease and other metabolic myopathies.
Multiple Acyl Coenzyme A Dehydrogenase Deficiency
[Application of tandem mass spectrometry on the diagnosis of fatty acid oxidation disorders]
Multiple Acyl Coenzyme A Dehydrogenase Deficiency
[Tandem mass spectrometry analysis and genetic diagnosis of neonates with fatty acid oxidation disorders in central and northern regions of Guangxi].
Multiple Carboxylase Deficiency
Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: a four-year report.
Multiple Sclerosis
CPT1A plays a key role in the development and treatment of multiple sclerosis and experimental autoimmune encephalomyelitis.
Multiple Sclerosis
The distribution of white blood cell fat oxidation in health and disease.
Muscle Cramp
Fuel utilization in subjects with carnitine palmitoyltransferase 2 gene mutations.
Muscle Cramp
[Rhabdomyolysis in carnitine palmitoyltransferase II deficiency: developments in pathophysiology, diagnosis and therapy]
Muscle Weakness
Carnitine palmitoyltransferase deficiency in a college athlete: a case report and literature review.
Muscle Weakness
No carnitine palmitoyltransferase deficiency in skeletal muscle in 18 malignant hyperthermia susceptible individuals.
Muscle Weakness
Phenotype of carnitine palmitoyltransferase II (CPT II) deficiency: A questionnaire-based survey.
Muscle Weakness
Stabilization of the thermolabile variant S113L of carnitine palmitoyltransferase II.
Muscular Diseases
A case of partial carnitine palmitoyltransferase deficiency in a patient undergoing chronic hemodialysis.
Muscular Diseases
A variable myopathy associated with heterozygosity for the R503C mutation in the carnitine palmitoyltransferase II gene.
Muscular Diseases
Biochemical and molecular correlations in carnitine palmitoyltransferase II deficiency.
Muscular Diseases
Carnitine and carnitine palmitoyltransferase in fatty acid oxidation and ketosis.
Muscular Diseases
Carnitine palmitoyltransferase type 2 deficiency: novel mutation in a Native South American family with whole-body muscle magnetic resonance imaging findings: two case reports.
Muscular Diseases
CPT2 gene mutations resulting in lethal neonatal or severe infantile carnitine palmitoyltransferase II deficiency.
Muscular Diseases
Fluxomic assay-assisted diagnosis orientation in a cohort of 11 patients with myopathic form of CPT2 deficiency.
Muscular Diseases
High frequency of ETFDH c.250G>A mutation in Taiwanese patients with late-onset lipid storage myopathy.
Muscular Diseases
Hypercholesterolemia treatment in a patient with family hypercholesterolemia and myopathy due to carnitine palmitoyltransferase II deficiency with PCSK9 inhibitors.
Muscular Diseases
Increased serum lactate dehydrogenase isoenzyme 1 and "flipped" LD-1/LD-2 ratio in myopathy associated with partial carnitine palmitoyltransferase deficiency.
Muscular Diseases
Mutation and biochemical analysis in carnitine palmitoyltransferase type II (CPT II) deficiency.
Muscular Diseases
No carnitine palmitoyltransferase deficiency in skeletal muscle in 18 malignant hyperthermia susceptible individuals.
Muscular Diseases
Partial muscle carnitine palmitoyltransferase-A deficiency. Rhabdomyolysis associated with transiently decreased muscle carnitine content after ibuprofen therapy.
Muscular Diseases
Recurrent Myalgia since Early Infancy-Misleading Clinical Course in a Child with Carnitine Palmitoyltransferase-II Deficiency.
Muscular Diseases
Repeat MRI in acute rhabdomyolysis: correlation with clinicopathological findings.
Muscular Diseases
Rhabdomyolysis and respiratory failure: rare presentation of carnitine palmityl-transferase II deficiency.
Muscular Diseases
Severe rhabdomyolysis in homozygote carnitine palmitoyltransferase II deficiency.
Muscular Diseases
Therapeutic advances in the management of Pompe disease and other metabolic myopathies.
Muscular Diseases
[Carnitine palmitoyltransferase deficiency: fatty acid utilization defect causing myopathy]
Muscular Diseases
[Exploration of exercise intolerance by 31P NMR spectroscopy of calf muscles coupled with MRI and ergometry]
Muscular Diseases
[Myopathy due to carnitine palmitoyltransferase deficiency. Report of 2 cases with enzymatic analyses on muscle tissue]
Muscular Diseases
[Myopathy in the course of carnitine palmitoyltransferase II deficiency].
Myalgia
A variable myopathy associated with heterozygosity for the R503C mutation in the carnitine palmitoyltransferase II gene.
Myalgia
Anesthetic management of a parturient with carnitine palmitoyltransferase II deficiency.
Myalgia
Carnitine Palmitoyltransferase II Deficiency (CPT II) Followed By Rhabdomyolysis and Acute Kidney Injury.
Myalgia
Carnitine palmitoyltransferase II deficiency with normal carnitine palmitoyltransferase I in skeletal muscle and leucocytes.
Myalgia
Clinical and biochemical heterogeneity in an Italian family with CPT II deficiency due to Ser 113 Leu mutation.
Myalgia
Clinical features and new molecular findings in Carnitine Palmitoyltransferase II (CPT II) deficiency.
Myalgia
Clinically symptomatic heterozygous carnitine palmitoyltransferase II (CPT II) deficiency.
Myalgia
Exercise tolerance in carnitine palmitoyltransferase II deficiency with IV and oral glucose.
Myalgia
Long-term follow-up of bezafibrate treatment in patients with the myopathic form of carnitine palmitoyltransferase 2 deficiency.
Myalgia
Muscle carnitine palmitoyltransferase II deficiency: clinical and molecular genetic features and diagnostic aspects.
Myalgia
Novel mutation in the CPT II gene in a child with periodic febrile myalgia and myoglobinuria.
Myalgia
Recurrent myoglobinuria due to carnitine palmitoyltransferase II deficiency: clinical, biochemical, and genetic features of adult-onset cases.
Myalgia
Recurrent rhabdomyolysis caused by carnitine palmitoyltransferase II deficiency, common but under-recognised: Lessons to be learnt.
Myalgia
Severe periodic febrile myalgia in infancy due to carnitine palmitoyltransferase deficiency.
Myocardial Infarction
Single nucleotide polymorphism in CPT1B and CPT2 genes and its association with blood carnitine levels in acute myocardial infarction patients.
Myoglobinuria
A variable myopathy associated with heterozygosity for the R503C mutation in the carnitine palmitoyltransferase II gene.
Myoglobinuria
Anesthetic management of a parturient with carnitine palmitoyltransferase II deficiency.
Myoglobinuria
Biochemical and molecular correlations in carnitine palmitoyltransferase II deficiency.
Myoglobinuria
Carnitine palmitoyltransferase deficiency in a college athlete: a case report and literature review.
Myoglobinuria
Carnitine palmitoyltransferase deficiency: a common cause of recurrent myoglobinuria.
Myoglobinuria
Carnitine Palmitoyltransferase II Deficiency (CPT II) Followed By Rhabdomyolysis and Acute Kidney Injury.
Myoglobinuria
Carnitine palmitoyltransferase II deficiency with normal carnitine palmitoyltransferase I in skeletal muscle and leucocytes.
Myoglobinuria
Carnitine palmitoyltransferase II deficiency: a new cause of recurrent pancreatitis.
Myoglobinuria
Clinical and biochemical heterogeneity in an Italian family with CPT II deficiency due to Ser 113 Leu mutation.
Myoglobinuria
Clinical features and new molecular findings in Carnitine Palmitoyltransferase II (CPT II) deficiency.
Myoglobinuria
Clinical varieties of carnitine and carnitine palmitoyltransferase deficiency.
Myoglobinuria
Exercise tolerance in carnitine palmitoyltransferase II deficiency with IV and oral glucose.
Myoglobinuria
Exercise-induced recurrent myoglobinuria: defective activity of inner carnitine palmitoyltransferase in muscle mitochondria of two patients.
Myoglobinuria
Fuel utilization in subjects with carnitine palmitoyltransferase 2 gene mutations.
Myoglobinuria
Identification of a common mutation in the carnitine palmitoyltransferase II gene in familial recurrent myoglobinuria patients.
Myoglobinuria
Identification of novel mutations in Spanish patients with muscle carnitine palmitoyltransferase II deficiency.
Myoglobinuria
Malonyl-CoA abnormal inhibition of residual enzyme activity in carnitine palmitoyltransferase deficiency.
Myoglobinuria
Muscle carnitine palmitoyltransferase II deficiency: clinical and molecular genetic features and diagnostic aspects.
Myoglobinuria
Normal muscle CPT1 and CPT2 activities in hepatic presentation patients with CPT1 deficiency in fibroblasts. Tissue specific isoforms of CPT1?
Myoglobinuria
Novel mutation in the CPT II gene in a child with periodic febrile myalgia and myoglobinuria.
Myoglobinuria
Novel mutations associated with carnitine palmitoyltransferase II deficiency.
Myoglobinuria
Recurrent myoglobinuria due to carnitine palmitoyltransferase II deficiency: clinical, biochemical, and genetic features of adult-onset cases.
Myoglobinuria
Recurrent myoglobinuria due to carnitine palmitoyltransferase II deficiency: expression of the molecular phenotype in cultured muscle cells.
Myoglobinuria
Recurrent rhabdomyolysis caused by carnitine palmitoyltransferase II deficiency, common but under-recognised: Lessons to be learnt.
Myoglobinuria
Regulatory properties of a mutant carnitine palmitoyltransferase in human skeletal muscle.
Myoglobinuria
Rhabdomyolysis and respiratory failure: rare presentation of carnitine palmityl-transferase II deficiency.
Myoglobinuria
Stabilization of the thermolabile variant S113L of carnitine palmitoyltransferase II.
Myoglobinuria
[Myoglobinuria and carnitine palmitoyltransferase deficiency. Diagnostic procedure and differential diagnosis]
Myoglobinuria
[Myoglobinuria due to a deficiency of carnitine palmitoyltransferase II. A clinical case report]
Myoglobinuria
[Recurrent myoglobinuria in a girl due to carnitine palmitoyltransferase deficiency]
Myoglobinuria
[Rhabdomyolysis in carnitine palmitoyltransferase II deficiency: developments in pathophysiology, diagnosis and therapy]
Myoglobinuria
[Type II carnitine palmitoyl transferase deficiency complicated by acute respiratory failure]
Narcolepsy
Identification of the Variations in the CPT1B and CHKB Genes Along with the HLA-DQB1*06:02 Allele in Turkish Narcolepsy Patients and Healthy Persons.
Narcolepsy
Polymorphism located between CPT1B and CHKB, and HLA-DRB1*1501-DQB1*0602 haplotype confer susceptibility to CNS hypersomnias (essential hypersomnia).
Narcolepsy
[Experimental Approach to Analysis of the Relationship between Food Environments and Lifestyle-Related Diseases, Including Cardiac Hypertrophy, Fatty Liver, and Fatigue Symptoms].
Nasopharyngeal Carcinoma
PGC1?/CEBPB/CPT1A axis promotes radiation resistance of nasopharyngeal carcinoma through activating fatty acid oxidation.
Neonatal Sepsis
Differential effects of neonatal endotoxemia on heart and kidney carnitine palmitoyl transferase I.
Neonatal Sepsis
Myocardial carnitine palmitoyltransferase I as a target for oxidative modification in inflammation and sepsis.
Neoplasm Metastasis
Carnitine palmitoyl transferase 1A is a novel diagnostic and predictive biomarker for breast cancer.
Neoplasm Metastasis
Carnitine palmitoyl transferase-1A (CPT1A): a new tumor specific target in human breast cancer.
Neoplasm Metastasis
Carnitine palmitoyltransferase 1A (CPT1A): a transcriptional target of PAX3-FKHR and mediates PAX3-FKHR-dependent motility in alveolar rhabdomyosarcoma cells.
Neoplasm Metastasis
CPT1A regulates breast cancer-associated lymphangiogenesis via VEGF signaling.
Neoplasm Metastasis
Development of a Genetic and Clinical Data-Based (GC) Risk Score for Predicting Survival of Hepatocellular Carcinoma Patients After Tumor Resection.
Neoplasm Metastasis
Inhibition of carnitine palmitoyl transferase 1A-induced fatty acid oxidation suppresses cell progression in gastric cancer.
Neoplasm Metastasis
Multi-omics Integration Analysis Robustly Predicts High-Grade Patient Survival and Identifies CPT1B Effect on Fatty Acid Metabolism in Bladder Cancer.
Neoplasms
A novel miR-1291-ERR?-CPT1C axis modulates tumor cell proliferation, metabolism and tumorigenesis.
Neoplasms
A sib-pair analysis study of 15 candidate genes in French families with morbid obesity: indication for linkage with islet 1 locus on chromosome 5q.
Neoplasms
Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease.
Neoplasms
Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells.
Neoplasms
Anti-Obesity Effect of T. Chebula Fruit Extract on High Fat Diet Induced Obese Mice: A Possible Alternative Therapy.
Neoplasms
Biolabel-led research pattern positions the effects and mechanisms of Sophorae Tonkinensis radix et rhizome on lung diseases: A novel strategy for computer-aided herbal medicine research based on omics and bioinformatics.
Neoplasms
C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity.
Neoplasms
Cardiac metabolism, inflammation, and peroxisome proliferator-activated receptors modulated by 1,25-dihydroxyvitamin D3 in diabetic rats.
Neoplasms
Carnitine palmitoyl transferase 1A is a novel diagnostic and predictive biomarker for breast cancer.
Neoplasms
Carnitine palmitoyl transferase-1A (CPT1A): a new tumor specific target in human breast cancer.
Neoplasms
Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer.
Neoplasms
Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress.
Neoplasms
Carnitine palmitoyltransferase 1C regulates cancer cell senescence through mitochondria-associated metabolic reprograming.
Neoplasms
Carnitine palmitoyltransferase 1C reverses cellular senescence of MRC-5 fibroblasts via regulating lipid accumulation and mitochondrial function.
Neoplasms
Carnitine palmitoyltransferase II activity is decreased in liver mitochondria of cachectic rats bearing the Walker 256 carcinosarcoma: effect of indomethacin treatment.
Neoplasms
CPT1A and fatty acid ?-oxidation are essential for tumor cell growth and survival in hormone receptor-positive breast cancer.
Neoplasms
CPT1A Supports Castration-Resistant Prostate Cancer in Androgen-Deprived Conditions.
Neoplasms
CPT1C promotes human mesenchymal stem cells survival under glucose deprivation through the modulation of autophagy.
Neoplasms
Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis.
Neoplasms
Depletion of the novel p53-target gene carnitine palmitoyltransferase 1C delays tumor growth in the neurofibromatosis type I tumor model.
Neoplasms
Development of a Genetic and Clinical Data-Based (GC) Risk Score for Predicting Survival of Hepatocellular Carcinoma Patients After Tumor Resection.
Neoplasms
Down-regulation of the phosphoenolpyruvate carboxykinase gene in human colon tumors and induction by omega-3 fatty acids.
Neoplasms
Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet.
Neoplasms
Elevated expression of fatty acid synthase and nuclear localization of carnitine palmitoyltransferase 1C are common among human gliomas.
Neoplasms
Enhancing cancer-associated fibroblast fatty acid catabolism within a metabolically challenging tumor microenvironment drives colon cancer peritoneal metastasis.
Neoplasms
Expression of Lipid Metabolism-Related Proteins Differs between Invasive Lobular Carcinoma and Invasive Ductal Carcinoma.
Neoplasms
Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer.
Neoplasms
Fatty acid oxidation is associated with proliferation and prognosis in breast and other cancers.
Neoplasms
Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity.
Neoplasms
Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells.
Neoplasms
Functional genomic characterization of delipidation elicited by trans-10, cis-12-conjugated linoleic acid (t10c12-CLA) in a polygenic obese line of mice.
Neoplasms
Gamma-linolenic acid alters the composition of mitochondrial membrane subfractions, decreases outer mitochondrial membrane binding of hexokinase and alters carnitine palmitoyltransferase I properties in the Walker 256 rat tumour.
Neoplasms
Genetic alterations in fatty acid transport and metabolism genes are associated with metastatic progression and poor prognosis of human cancers.
Neoplasms
Genetics and molecular biology: fatty acid metabolism in cancer cell survival; carnitine palmitoyltransferase-1 as a critical anticancer target.
Neoplasms
Glioblastoma Utilizes Fatty Acids and Ketone Bodies for Growth Allowing Progression during Ketogenic Diet Therapy.
Neoplasms
HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism.
Neoplasms
High Expression of CPT1A Predicts Adverse Outcomes: A Potential Therapeutic Target for Acute Myeloid Leukemia.
Neoplasms
High-fat diet-activated fatty acid oxidation mediates intestinal stemness and tumorigenicity.
Neoplasms
Human and rat tumour cells possess mitochondrial carnitine palmitoyltransferase I and II: effects of insulin.
Neoplasms
Identification of CPT1A as a Prognostic Biomarker and Potential Therapeutic Target for Kidney Renal Clear Cell Carcinoma and Establishment of a Risk Signature of CPT1A-Related Genes.
Neoplasms
Identifying off-target effects of etomoxir reveals that carnitine palmitoyltransferase I is essential for cancer cell proliferation independent of ?-oxidation.
Neoplasms
Immunodetection of rat Walker 256 tumour mitochondrial carnitine palmitoyltransferase I and II: evidence for the control of CPT II expression by insulin.
Neoplasms
In vivo inhibition of Walker 256 tumour carnitine palmitoyltransferase I by soya oil dietary supplementation.
Neoplasms
Induction of apoptosis by polyunsaturated fatty acids and its relationship to fatty acid inhibition of carnitine palmitoyltransferase I activity in Hep2 cells.
Neoplasms
Influence of DMBA-induced mammary cancer on the liver CPT I, mit HMG-CoA synthase and PPARalpha mRNA expression in rats fed a low or high corn oil diet.
Neoplasms
Inhibition of carnitine palmitoyl transferase 1A-induced fatty acid oxidation suppresses cell progression in gastric cancer.
Neoplasms
Inhibition of CPT1a as a prognostic marker can synergistically enhance the antileukemic activity of ABT199.
Neoplasms
Intracellular mechanisms underlying lipid accumulation (white opaque substance) in gastric epithelial neoplasms: A pilot study of expression profiles of lipid-metabolism-associated genes.
Neoplasms
iRGD-modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation.
Neoplasms
L-carnitine ameliorates cancer cachexia in mice by regulating the expression and activity of carnitine palmityl transferase.
Neoplasms
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade.
Neoplasms
Lipidomics reveals carnitine palmitoyltransferase 1C protects cancer cells from lipotoxicity and senescence.
Neoplasms
Loss of tumor suppressive properties of lipid metabolism enzyme CPT2 in ovarian carcinoma: Comment on "CPT2 down-regulation promotes tumor growth and metastasis through inducing ROS/NF?B pathway in ovarian cancer" by Zhang et al.
Neoplasms
Mechanism of apoptosis induced by the inhibition of fatty acid synthase in breast cancer cells.
Neoplasms
Metabolic fate and effects of saturated and unsaturated fatty acids in Hep2 human larynx tumor cells.
Neoplasms
Metabolic Pathway Signatures Associated with Urinary Metabolite Biomarkers Differentiate Bladder Cancer Patients from Healthy Controls.
Neoplasms
Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47-mediated 'don't-eat-me' signal.
Neoplasms
Molecular Pathways: Tumors cells co-opt the brain-specific metabolism gene CPT1C to promote survival.
Neoplasms
Multi-omics Integration Analysis Robustly Predicts High-Grade Patient Survival and Identifies CPT1B Effect on Fatty Acid Metabolism in Bladder Cancer.
Neoplasms
Myocardial expression profiles of candidate molecules in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia compared to those with dilated cardiomyopathy and healthy controls.
Neoplasms
n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Neoplasms
N6-methyladenosine-induced ERR? triggers chemoresistance of cancer cells through upregulation of ABCB1 and metabolic reprogramming.
Neoplasms
Nobiletin improves obesity and insulin resistance in high-fat diet-induced obese mice.
Neoplasms
PGC-1? activator-induced fatty acid oxidation in tumor-infiltrating CTLs enhances effects of PD-1 blockade therapy in lung cancer.
Neoplasms
Polymorphisms in CPT1B and CPT2 have no significant effect on plasma carnitine levels in Japanese cancer patients.
Neoplasms
PPAR? regulates tumor cell proliferation and senescence via a novel target gene carnitine palmitoyltransferase 1C.
Neoplasms
Prognostic Value of the Overexpression of Fatty Acid Metabolism-Related Enzymes in Squamous Cell Carcinoma of the Head and Neck.
Neoplasms
Regulation of tumour cell fatty acid oxidation by n-6 polyunsaturated fatty acids.
Neoplasms
Significance of thymidine phosphorylase in metronomic chemotherapy using CPT-11 and doxifluridine for advanced colorectal carcinoma.
Neoplasms
Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy.
Neoplasms
Targeting CPT1B as a potential therapeutic strategy in castration-resistant and enzalutamide-resistant prostate cancer.
Neoplasms
Targeting Fat Oxidation in Mouse Prostate Cancer Decreases Tumor Growth and Stimulates Anti-Cancer Immunity.
Neoplasms
Tumor-induced alterations in hepatic malic enzyme and carnitine palmitoyltransferase activity.
Neoplasms
Upregulation of CPT1A is essential for the tumor-promoting effect of adipocytes in colon cancer.
Nervous System Malformations
Lethal neonatal deficiency of carnitine palmitoyltransferase II associated with dysgenesis of the brain and kidneys.
Neurofibromatoses
Depletion of the novel p53-target gene carnitine palmitoyltransferase 1C delays tumor growth in the neurofibromatosis type I tumor model.
Neurofibromatosis 1
Depletion of the novel p53-target gene carnitine palmitoyltransferase 1C delays tumor growth in the neurofibromatosis type I tumor model.
Neuroleptic Malignant Syndrome
Genetic analysis of ryanodine receptor 1 gene and carnitine palmitoyltransferase II gene: An autopsy case of neuroleptic malignant syndrome related to vegetamin.
Non-alcoholic Fatty Liver Disease
?-Tocopherol suppresses hepatic steatosis by increasing CPT-1 expression in a mouse model of diet-induced nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Activation of the Peroxisome Proliferator-Activated Receptors (PPAR-?/?) and the Fatty Acid Metabolizing Enzyme Protein CPT1A by Camel Milk Treatment Counteracts the High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease.
Non-alcoholic Fatty Liver Disease
Alogliptin alleviates hepatic steatosis in a mouse model of nonalcoholic fatty liver disease by promoting CPT1a expression via Thr172 phosphorylation of AMPK? in the liver.
Non-alcoholic Fatty Liver Disease
Beneficial effects of neomangiferin on high fat diet-induced nonalcoholic fatty liver disease in rats.
Non-alcoholic Fatty Liver Disease
Gan-Jiang-Ling-Zhu decoction alleviates hepatic steatosis in rats by the miR-138-5p/CPT1B axis.
Non-alcoholic Fatty Liver Disease
Genome-wide analysis of DNA methylation in human peripheral leukocytes identifies potential biomarkers of nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Gynostemma pentaphyllum Attenuates the Progression of Nonalcoholic Fatty Liver Disease in Mice: A Biomedical Investigation Integrated with In Silico Assay.
Non-alcoholic Fatty Liver Disease
Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD.
Non-alcoholic Fatty Liver Disease
n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Non-alcoholic Fatty Liver Disease
Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Ppar?).
Non-alcoholic Fatty Liver Disease
Resveratrol improves high fat diet-induced fatty liver and insulin resistance by concomitant inhibiting proteolytic cleavage of SREBPS , FFAs oxidation, and intestinal TGS absorption.
Non-alcoholic Fatty Liver Disease
Study on the protection of water extracts of Polygoni Multiflori Radix and Polygoni Multiflori Radix Praeparata against NAFLD and its mechanism.
Non-alcoholic Fatty Liver Disease
The water extract of Sophorae tonkinensis Radix et Rhizoma alleviates non-alcoholic fatty liver disease and its mechanism.
Non-alcoholic Fatty Liver Disease
TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation.
Non-alcoholic Fatty Liver Disease
[Effect of chitooligosaccharide on hepatic triglyceride metabolism and related mechanisms].
Obesity
A sib-pair analysis study of 15 candidate genes in French families with morbid obesity: indication for linkage with islet 1 locus on chromosome 5q.
Obesity
Anti-Obesity Effects of Poly-?-glutamic Acid with or without Isoflavones on High-Fat Diet Induced Obese Mice.
Obesity
Blood Cells as a Source of Transcriptional Biomarkers of Childhood Obesity and Its Related Metabolic Alterations: Results of the IDEFICS Study.
Obesity
C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity.
Obesity
C75 [4-methylene-2-octyl-5-oxo-tetrahydro-furan-3-carboxylic acid] activates carnitine palmitoyltransferase-1 in isolated mitochondria and intact cells without displacement of bound malonyl CoA.
Obesity
Canagliflozin ameliorates obesity by improving mitochondrial function and fatty acid oxidation via PPAR? in vivo and in vitro.
Obesity
Carnitine palmitoyltransferase 1B 531K allele carriers sustain a higher respiratory quotient after aerobic exercise, but ?3-adrenoceptor 64R allele does not affect lipolysis: a human model.
Obesity
Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice.
Obesity
CPT1C in the ventromedial nucleus of the hypothalamus is necessary for brown fat thermogenesis activation in obesity.
Obesity
Differential epigenetic and transcriptional response of the skeletal muscle carnitine palmitoyltransferase 1B (CPT1B) gene to lipid exposure with obesity.
Obesity
Effect of Chronic CPT-1 Inhibition on Myocardial Ischemia-Reperfusion Injury (I/R) in a Model of Diet-Induced Obesity.
Obesity
Effects of hypoxic exercise training on microRNA expression and lipid metabolism in obese rat livers.
Obesity
Enhanced susceptibility of Cpt1c knockout mice to glucose intolerance induced by a high-fat diet involves elevated hepatic gluconeogenesis and decreased skeletal muscle glucose uptake.
Obesity
Examination of carnitine palmitoyltransferase 1 abundance in white adipose tissue: implications in obesity research.
Obesity
Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects.
Obesity
Genetic polymorphisms in carnitine palmitoyltransferase 1A gene are associated with variation in body composition and fasting lipid traits in Yup'ik Eskimos.
Obesity
Hypothalamic ceramide levels regulated by CPT1C mediate the orexigenic effect of ghrelin.
Obesity
Hypothalamic Regulation of Liver and Muscle Nutrient Partitioning by Brain-Specific Carnitine Palmitoyltransferase 1C in Male Mice.
Obesity
Impaired oxidative capacity due to decreased CPT1b levels as a contributing factor to fat accumulation in obesity.
Obesity
Influence of breastfeeding on blood-cell transcript-based biomarkers of health in children.
Obesity
Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD.
Obesity
Loss of Muscle Carnitine Palmitoyltransferase 2 Prevents Diet-Induced Obesity and Insulin Resistance despite Long-Chain Acylcarnitine Accumulation.
Obesity
Metabolism as a tool for understanding human brain evolution: lipid energy metabolism as an example.
Obesity
Methylation loci associated with body mass index, waist circumference, and waist-to-hip ratio in Chinese adults: an epigenome-wide analysis.
Obesity
Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation.
Obesity
Poly-ion complex micelles effectively deliver CoA-conjugated CPT1A inhibitors to modulate lipid metabolism in brain cells.
Obesity
Positive regulation of hepatic carnitine palmitoyl transferase 1A (CPT1A) activities by soy isoflavones and L-carnitine.
Obesity
SUMO-Specific Protease 2 (SENP2) Is an Important Regulator of Fatty Acid Metabolism in Skeletal Muscle.
Obesity
The hepatokine FGF21 is crucial for peroxisome proliferator-activated receptor-? agonist-induced amelioration of metabolic disorders in obese mice.
Obesity
The impact of CPT1B rs470117, LEPR rs1137101 and BDNF rs6265 polymorphisms on the risk of developing obesity in an Italian population.
Obesity
The Loss Of Macrophage Fatty Acid Oxidation Does Not Potentiate Systemic Metabolic Dysfunction.
Obesity
Theobromine ameliorates nonalcoholic fatty liver disease by regulating hepatic lipid metabolism via mTOR signaling pathway in vivo and in vitro.
Obesity
Therapeutic promises of Chlorogenic acid with special emphasis on its anti-obesity property.
Obesity
Ultra-fast simultaneous detection of obesity-related coenzymes in mice using microchip electrophoresis with a LIF detector.
Obesity
Use of human PBMC to analyse the impact of obesity on lipid metabolism and metabolic status: a proof-of-concept pilot study.
Obesity
Variants within the muscle and liver isoforms of the carnitine palmitoyltransferase I (CPT1) gene interact with fat intake to modulate indices of obesity in French-Canadians.
Obesity, Morbid
Differential epigenetic and transcriptional response of the skeletal muscle carnitine palmitoyltransferase 1B (CPT1B) gene to lipid exposure with obesity.
ornithine carbamoyltransferase deficiency
Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: a four-year report.
ornithine carbamoyltransferase deficiency
Targeted metabolomic analysis of plasma samples for the diagnosis of inherited metabolic disorders.
Ornithine Carbamoyltransferase Deficiency Disease
Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: a four-year report.
Ornithine Carbamoyltransferase Deficiency Disease
Targeted metabolomic analysis of plasma samples for the diagnosis of inherited metabolic disorders.
Osteoporosis
Functional relevance for associations between osteoporosis and genetic variants.
Otitis Media
Association of the CPT1A p.P479L Metabolic Gene Variant With Childhood Respiratory and Other Infectious Illness in Nunavut.
Ovarian Neoplasms
Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer.
Overweight
Blood Cells as a Source of Transcriptional Biomarkers of Childhood Obesity and Its Related Metabolic Alterations: Results of the IDEFICS Study.
Pancreatic Neoplasms
A novel miR-1291-ERR?-CPT1C axis modulates tumor cell proliferation, metabolism and tumorigenesis.
Pancreatitis
Carnitine palmitoyltransferase II deficiency: a new cause of recurrent pancreatitis.
pantoate-beta-alanine ligase (amp-forming) deficiency
Targeted metabolomic analysis of plasma samples for the diagnosis of inherited metabolic disorders.
Paresis
Clinically symptomatic heterozygous carnitine palmitoyltransferase II (CPT II) deficiency.
peptidyl-glutamate 4-carboxylase deficiency
Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: a four-year report.
Peripheral Nervous System Diseases
Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial.
Peripheral Nervous System Diseases
Trifunctional enzyme deficiency: adult presentation of a usually fatal beta-oxidation defect.
Phenylketonurias
Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: a four-year report.
Phenylketonurias
Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program.
Placenta Accreta
An unusual case of placenta increta in a Carnitine palmitoyltransferase deficiency carrier.
Polycystic Kidney Diseases
Carnitine palmitoyltransferase II deficiency in a prenatal case with polycystic kidney disease-like phenotype.
Polymyositis
Repeat MRI in acute rhabdomyolysis: correlation with clinicopathological findings.
Pregnancy Complications
High glucose levels reduce fatty acid oxidation and increase triglyceride accumulation in human placenta.
Pregnancy Complications
Serious pregnancy complications in a patient with previously undiagnosed carnitine palmitoyltransferase 1 deficiency.
Propionic Acidemia
Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program.
Propionic Acidemia
Targeted metabolomic analysis of plasma samples for the diagnosis of inherited metabolic disorders.
Prostatic Neoplasms
Cationic Polymer Nanoparticles-Mediated Delivery of miR-124 Impairs Tumorigenicity of Prostate Cancer Cells.
Prostatic Neoplasms
CPT1A Over-Expression Increases Reactive Oxygen Species in the Mitochondria and Promotes Antioxidant Defenses in Prostate Cancer.
Prostatic Neoplasms
CPT1A Supports Castration-Resistant Prostate Cancer in Androgen-Deprived Conditions.
Prostatic Neoplasms
Deregulation of MicroRNAs mediated control of carnitine cycle in prostate cancer: molecular basis and pathophysiological consequences.
Prostatic Neoplasms
Targeting CPT1B as a potential therapeutic strategy in castration-resistant and enzalutamide-resistant prostate cancer.
Prostatic Neoplasms
Targeting prostate cancer cell metabolism: impact of hexokinase and CPT-1 enzymes.
Protein Deficiency
Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts.
Proteinuria
High-calorie diet partially ameliorates dysregulation of intrarenal lipid metabolism in remnant kidney.
Proteinuria
Niacin improves renal lipid metabolism and slows progression in chronic kidney disease.
Psoriasis
A new therapeutic approach to treat psoriasis by inhibition of fatty acid oxidation by Etomoxir.
pyruvate decarboxylase deficiency
[Lipid storage myopathies--carnitine deficiency, carnitine palmitoyltransferase deficiency, pyruvate decarboxylase deficiency]
Pyruvate Dehydrogenase Complex Deficiency Disease
[Lipid storage myopathies--carnitine deficiency, carnitine palmitoyltransferase deficiency, pyruvate decarboxylase deficiency]
Renal Insufficiency
[Rhabdomyolysis caused by carnitine palmitoyltransferase deficiency. Prevention of acute kidney failure]
Reperfusion Injury
Effect of Chronic CPT-1 Inhibition on Myocardial Ischemia-Reperfusion Injury (I/R) in a Model of Diet-Induced Obesity.
Reperfusion Injury
Reducing the Burden of Ischemia Reperfusion : Editorial to: "Effect of Chronic CPT-1 Inhibition on Myocardial Ischemia-Reperfusion Injury (I/R) in a Model of Diet-Induced Obesity" by G. Maarman et al.
Respiratory Insufficiency
Partial muscle carnitine palmitoyltransferase-A deficiency. Rhabdomyolysis associated with transiently decreased muscle carnitine content after ibuprofen therapy.
Respiratory Insufficiency
Rhabdomyolysis and respiratory failure: rare presentation of carnitine palmityl-transferase II deficiency.
Respiratory Insufficiency
[Acute respiratory insufficiency and carnitine palmitoyltransferase deficiency]
Respiratory Insufficiency
[Type II carnitine palmitoyl transferase deficiency complicated by acute respiratory failure]
Retinoblastoma
Microarray analysis of perichondral and reserve growth plate zones identifies differential gene expressions and signal pathways.
Reye Syndrome
Carnitine palmitoyltransferase 1A deficiency: abnormal muscle biopsy findings in a child presenting with Reye's syndrome.
Reye Syndrome
Expression analysis of two mutations in carnitine palmitoyltransferase IA deficiency.
Rhabdomyolysis
A variable myopathy associated with heterozygosity for the R503C mutation in the carnitine palmitoyltransferase II gene.
Rhabdomyolysis
An ignored cause of red urine in children: rhabdomyolysis due to carnitine palmitoyltransferase II (CPT-II) deficiency.
Rhabdomyolysis
Anesthetic management of a parturient with carnitine palmitoyltransferase II deficiency.
Rhabdomyolysis
Biochemical evidence for heterozygosity in muscular carnitine palmitoyltransferase deficiency.
Rhabdomyolysis
Carnitine palmitoyl transferase II deficiency in an adolescent presenting with rhabdomyolysis and acute renal failure.
Rhabdomyolysis
Carnitine palmitoyltransferase deficiency in a college athlete: a case report and literature review.
Rhabdomyolysis
Carnitine Palmitoyltransferase II Deficiency (CPT II) Followed By Rhabdomyolysis and Acute Kidney Injury.
Rhabdomyolysis
Carnitine palmitoyltransferase II deficiency and post-COVID vaccination rhabdomyolysis.
Rhabdomyolysis
Carnitine palmitoyltransferase II deficiency due to a novel gene variant in a patient with rhabdomyolysis and ARF.
Rhabdomyolysis
Carnitine palmitoyltransferase II deficiency: successful anaplerotic diet therapy.
Rhabdomyolysis
Cause of recurrent rhabdomyolysis, carnitine palmitoyltransferase II deficiency and novel pathogenic mutation.
Rhabdomyolysis
Clinical and genetic characteristics of patients with fatty acid oxidation disorders identified by newborn screening.
Rhabdomyolysis
Clinically symptomatic heterozygous carnitine palmitoyltransferase II (CPT II) deficiency.
Rhabdomyolysis
Diagnostic assessment and long-term follow-up of 13 patients with Very Long-Chain Acyl-Coenzyme A dehydrogenase (VLCAD) deficiency.
Rhabdomyolysis
First Japanese Case of Carnitine Palmitoyltransferase II Deficiency with the Homozygous Point Mutation S113L.
Rhabdomyolysis
Functional analysis of iPSC-derived myocytes from a patient with carnitine palmitoyltransferase II deficiency.
Rhabdomyolysis
Genetic analysis of ryanodine receptor 1 gene and carnitine palmitoyltransferase II gene: An autopsy case of neuroleptic malignant syndrome related to vegetamin.
Rhabdomyolysis
Long-term follow-up of bezafibrate treatment in patients with the myopathic form of carnitine palmitoyltransferase 2 deficiency.
Rhabdomyolysis
Macro creatine kinase in a case of carnitine palmitoyltransferase deficiency.
Rhabdomyolysis
No carnitine palmitoyltransferase deficiency in skeletal muscle in 18 malignant hyperthermia susceptible individuals.
Rhabdomyolysis
Partial muscle carnitine palmitoyltransferase-A deficiency. Rhabdomyolysis associated with transiently decreased muscle carnitine content after ibuprofen therapy.
Rhabdomyolysis
Postinfectious Rhabdomyolysis in a 5-Year-Old Boy: When to Look a Little Deeper.
Rhabdomyolysis
Recurrent rhabdomyolysis associated with influenza-like illness in a weight-lifter.
Rhabdomyolysis
Recurrent rhabdomyolysis caused by carnitine palmitoyltransferase II deficiency, common but under-recognised: Lessons to be learnt.
Rhabdomyolysis
Repeated and progressive rhabdomyolysis due to a novel carnitine palmitoyltransferase II gene variant in an adult male: A case report.
Rhabdomyolysis
Rhabdomyolysis and Cardiomyopathy in a 20-Year-Old Patient with CPT II Deficiency.
Rhabdomyolysis
Rhabdomyolysis and respiratory failure: rare presentation of carnitine palmityl-transferase II deficiency.
Rhabdomyolysis
Rhabdomyolysis caused by carnitine palmitoyltransferase 2 deficiency: A case report and systematic review of the literature.
Rhabdomyolysis
Severe rhabdomyolysis in homozygote carnitine palmitoyltransferase II deficiency.
Rhabdomyolysis
Severe rhabdomyolysis with hypoglycemia in an adult patient with carnitine palmitoyltransferase II deficiency.
Rhabdomyolysis
Unmasking of carnitine palmitoyltransferase deficiency during an acute exacerbation of asthma complicated by rhabdomyolysis in a soldier.
Rhabdomyolysis
Valproic acid triggers acute rhabdomyolysis in a patient with carnitine palmitoyltransferase type II deficiency.
Rhabdomyolysis
[Abnormal regulation of carnitine palmitoyltransferase in monozygotic twins as the cause of rhabdomyolysis]
Rhabdomyolysis
[Acute renal insufficiency caused by rhabdomyolysis due to deficiency of carnitine palmitoyltransferase]
Rhabdomyolysis
[Carnitine palmitoyltransferase deficiency as the cause of effort rhabdomyolysis]
Rhabdomyolysis
[Rhabdomyolysis caused by carnitine palmitoyltransferase deficiency. Prevention of acute kidney failure]
Rhabdomyolysis
[Rhabdomyolysis in carnitine palmitoyltransferase II deficiency: developments in pathophysiology, diagnosis and therapy]
Rhabdomyosarcoma, Alveolar
Carnitine palmitoyltransferase 1A (CPT1A): a transcriptional target of PAX3-FKHR and mediates PAX3-FKHR-dependent motility in alveolar rhabdomyosarcoma cells.
Riboflavin Deficiency
Hepatic mitochondrial and peroxisomal oxidative capacity in riboflavin deficiency: effect of age, dietary fat and starvation in rats.
Riboflavin Deficiency
Transcriptional regulation of carnitine palmitoyltransferase synthesis in riboflavin deficiency in rats.
Sarcoma
Tumor-induced alterations in hepatic malic enzyme and carnitine palmitoyltransferase activity.
Seizures
Carnitine palmitoyltransferase 1A (CPT1A) P479L prevalence in live newborns in Yukon, Northwest Territories, and Nunavut.
Seizures
Normal muscle CPT1 and CPT2 activities in hepatic presentation patients with CPT1 deficiency in fibroblasts. Tissue specific isoforms of CPT1?
Sepsis
Differential effects of neonatal endotoxemia on heart and kidney carnitine palmitoyl transferase I.
Sepsis
Hepatic gene expression and cytokine responses to sterile inflammation: comparison with cecal ligation and puncture sepsis in the rat.
Sepsis
Myocardial carnitine palmitoyltransferase I as a target for oxidative modification in inflammation and sepsis.
Sepsis
The Ca2+ second messenger system and interleukin-1-alpha modulation of hepatic gene transcription and mitochondrial fat oxidation.
Sepsis
The effect of surgical treatment following peritoneal sepsis on hepatic gene expression.
Sepsis
The possible inhibitory role of the leucine-zipper DNA binding protein c-fos in the regulation of hepatic gene expression after sepsis.
short-chain acyl-coa dehydrogenase deficiency
Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: a four-year report.
short-chain acyl-coa dehydrogenase deficiency
Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program.
short-chain acyl-coa dehydrogenase deficiency
[Application of tandem mass spectrometry on the diagnosis of fatty acid oxidation disorders]
short-chain acyl-coa dehydrogenase deficiency
[Tandem mass spectrometry analysis and genetic diagnosis of neonates with fatty acid oxidation disorders in central and northern regions of Guangxi].
Sickle Cell Trait
Postoperative coma in a child with carnitine palmitoyltransferase I deficiency.
Sleep Deprivation
Blood-gene expression reveals reduced circadian rhythmicity in individuals resistant to sleep deprivation.
Spastic Paraplegia, Hereditary
A novel CPT1C variant causes pure hereditary spastic paraplegia with benign clinical course.
Spastic Paraplegia, Hereditary
Carnitine palmitoyltransferase 1C: From cognition to cancer.
Starvation
CPT1C promotes human mesenchymal stem cells survival under glucose deprivation through the modulation of autophagy.
Starvation
Cycloheximide blocks changes in rat liver carnitine palmitoyltransferase 1 activity in starvation.
Starvation
Dietary fatty acids influence the activity and metabolic control of mitochondrial carnitine palmitoyltransferase I in rat heart and skeletal muscle.
Starvation
Differential regulation of hepatic gene expression by starvation versus refeeding following a high-sucrose or high-fat diet.
Starvation
Effect of dietary ascorbate on lipogenesis and lipolysis activities in black sea bream, Acanthopagrus schlegelii.
Starvation
Effect of insulin on the properties of liver carnitine palmitoyltransferase in the starved rat: assessment by the euglycemic hyperinsulinemic clamp.
Starvation
Effect of starvation and diabetes on the sensitivity of carnitine palmitoyltransferase I to inhibition by 4-hydroxyphenylglyoxylate.
Starvation
Effect of starvation on hepatic acyl-CoA synthetase, carnitine palmitoyltransferase-I, and acetyl-CoA carboxylase mRNA levels in rats.
Starvation
Effects of starvation on the carnitine palmitoyltransferase of hepatic peroxisomes.
Starvation
Effects of thyroidectomy and starvation on the activity and properties of hepatic carnitine palmitoyltransferase.
Starvation
Exercise attenuates the fasting-induced transcriptional activation of metabolic genes in skeletal muscle.
Starvation
Hepatic mitochondrial and peroxisomal oxidative capacity in riboflavin deficiency: effect of age, dietary fat and starvation in rats.
Starvation
Hepatic mitochondrial function in ketogenic states. Diabetes, starvation, and after growth hormone administration.
Starvation
Hepatic mitochondrial inner membrane properties and carnitine palmitoyltransferase A and B. Effect of diabetes and starvation.
Starvation
Hepatic mitochondrial inner-membrane properties, beta-oxidation and carnitine palmitoyltransferases A and B. Effects of genetic obesity and starvation.
Starvation
Insulin regulates enzyme activity, malonyl-CoA sensitivity and mRNA abundance of hepatic carnitine palmitoyltransferase-I.
Starvation
Rat liver carnitine palmitoyltransferase 1 forms an oligomeric complex within the outer mitochondrial membrane.
Starvation
Rat liver mitochondrial carnitine palmitoyltransferase-I, hepatic carnitine, and malonyl-CoA: effect of starvation.
Starvation
Regulation of carnitine palmitoyltransferase activity in the liver and brown adipose tissue in the newborn rat: effect of starvation and hypothermia.
Starvation
Response to starvation of hepatic carnitine palmitoyltransferase activity and its regulation by malonyl-CoA. Sex differences and effects of pregnancy.
Starvation
The effect of malonyl-CoA on overt and latent carnitine acyltransferase activities in rat liver and adipocyte mitochondria.
Starvation
The role of changes in the sensitivity of hepatic mitochondrial overt carnitine palmitoyltransferase in determining the onset of the ketosis of starvation in the rat.
Starvation
Use of a selectively permeabilized isolated rat hepatocyte preparation to study changes in the properties of overt carnitine palmitoyltransferase activity in situ.
Status Epilepticus
A Case of Recurrent Acute Encephalopathy with Febrile Convulsive Status Epilepticus with Carnitine Palmitoyltransferase II Variation.
Status Epilepticus
Atypical presentation of carnitine palmitoyltransferase (CPT) deficiency as status epilepticus.
Stomach Neoplasms
Enhanced fatty acid oxidation mediated by CPT1C promotes gastric cancer progression.
Teratocarcinoma
NR4A nuclear receptors mediate carnitine palmitoyltransferase 1A gene expression by the rexinoid HX600.
Thyroid Cancer, Papillary
Cpt1c regulated by AMPK promotes papillary thyroid carcinomas cells survival under metabolic stress conditions.
Thyroid Carcinoma, Anaplastic
Growth inhibition of orthotopic anaplastic thyroid carcinoma xenografts in nude mice by PTK787/ZK222584 and CPT-11.
Triple Negative Breast Neoplasms
Dual inhibition of glutaminase and carnitine palmitoyltransferase decreases growth and migration of glutaminase inhibition-resistant triple-negative breast cancer cells.
Tyrosinemias
Targeted metabolomic analysis of plasma samples for the diagnosis of inherited metabolic disorders.
Urinary Bladder Neoplasms
Human and rat tumour cells possess mitochondrial carnitine palmitoyltransferase I and II: effects of insulin.
Urinary Bladder Neoplasms
Multi-omics Integration Analysis Robustly Predicts High-Grade Patient Survival and Identifies CPT1B Effect on Fatty Acid Metabolism in Bladder Cancer.
Vitamin B 12 Deficiency
Vitamin B12 and omega-3 fatty acids together regulate lipid metabolism in Wistar rats.
Vitamin D Deficiency
Vitamin D Deficiency Attenuates Acute Alcohol-Induced Hepatic Lipid Accumulation in Mice.
Zellweger Syndrome
Lethal neonatal deficiency of carnitine palmitoyltransferase II associated with dysgenesis of the brain and kidneys.
html completed